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I 
1, 
Abstract 
This thesis describes the isolation, purification and structure 
determination of antibiotic metabolites from three plants and a fungus 
which were selected based on their reported use as antiseptic remedies 
among Australian aborigines. The structures were determined using 
modern high field NMR pulse techniques, mass spectrometry, chemical 
derivatisation and synthesis of derivatives. 
Extracts from the first plant Lysiphyllum cunninghamii which has 
been used as an antiseptic wash, were examined using bioassay guided 
fractionation. Purification and structure elucidation of an antibacterial 
constituent, (-)-astilbin 3.1 is described. 
The second plant Persoonia linearis x pinifolia was chosen because an 
earlier screening for antibiotic activity showed the fruits from this plant to 
be active against Staphylococcus aureus (golden staph) and Salmonella typhi 
(typhoid). A novel antibiotic glycoside 3.2 was isolated from the fruits of P. 
linearis using bioassay guided fractionation. 
The third plant Pterocaulon serrulatum, one of the few plants which 
are dried and used by aborigines when fresh plant material is unobtainable, 
yielded two antibacterial sesquiterpenes 3.12 and 3.13, one antibacterial 
flavanone 3.11 and three inactive coumarins 3.8, 3.9 and 3.10 
I 
From the red bracket fungus Pycnoprorus cocczneus was isolated two 
antibiotic pigments 3.22 and 3.23 using bioassay guided fractionation. 
In addition to the isolation of antibiotic metabolites from Australian 
plants a synthesis of the oxindole alkaloid donaxaridine 4.5, isolated from 
the giant reed Arundo donax is described. 
The underlying strategy of the synthesis was to use inexpensive 
starting materials and simple reactions. Intermediates in the synthesis were 
thought to be useful in the elaboration of simple oxindoles into more 
complex indole alkaloids. 
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CHAPTER ONE 
INTRODUCTION 
l 
Chapter one 1 
Natural products & secondary metabolism 
The division of natural products into two categories belonging to either 
primary or secondary metabolism has long been the accepted standard. 
The classification was developed in the early days of biochemistry as the 
role of more and more compounds in living organisms was identified. 
The compounds which were essential for the survival and regeneration 
of the organism were called "primary metabolites" and the compounds 
without no apparent function were classified as secondary metabolites. 
The two types of compounds are connected, however, via a complex set 
of metabolic pathways as shown in Fig. 1.1.1 
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While this discrimination between primary and secondary 
metabolism is useful in a didactic way, the boundary between the two 
areas of metabolism is nevertheless imprecise. The sometimes 
ambiguous nature of this division can be illustrated by the following 
examples.2 Polyamines such as putrescine 1.1, spermidine 1.2 and 
spermine 1.3 and their associated biosynthetic enzymes are widespread in 
nature. They have a high affinity for DNA, they stimulate the synthesis 
of protein and there are microbial mutants which need polyamines for 
growth. These polyamines may look like essential metabolites but there 
is still no conclusive evidence to support this theory. 
putrescine 1.1 
H2N~N~NH2 
H 
spermidine 1.2 
H 
H2N~N~N~NH2 
H 
spermine 1.3 
The sesquiterpene diol sirenin 1.4 and the sulphated gallic acid glycoside 
K-PLMF 1 1.5 on the other hand have a restricted distribution in nature. 
They have the "look" of secondary metabolites but both play very specific 
and essential roles in the organisms where they are found. Sirenin is 
responsible for the attraction of male and female gametes in Allomyces 
species3 and it seems to be essential for reproduction. Similarly when 
some Acacia sp. fold their leaves at dusk - as if they were going to sleep -
the movement is caused by a change in hydrostatic pressure elicited by 
compounds called turgorins, which include K-PLMF 1.4 
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Several features of secondary metabolites set them apart from 
primary metabolites. These include the abundance of structural diversity; 
the fact that some secondary metabolites can be accumulated and reach 
comparatively high concentrations compared to their apparent lack of 
function; and the relatively high number of substances with some 
biological activity found amongst secondary metabolites. These features 
may or may not be part of the reason why they are biosynthesised (vide 
infra). 
The terpenes are ideal examples of the structural diversity exhibited 
by secondary metabolites. It is well established (mainly due to the work of 
Ruzicka and coworkersS,6) that the biosynthesis of terpenes is based on 
the condensation of isopentenyl pyrophosphate (IPP) and dimethylallyl 
pyrophosphate (DMAPP) to give geranyl pyrophosphate (GPP) (Fig. 1.2). 
Sequential condensations with IPP to give farnesyl pyrophosphate (FPP) 
and geranylgeranyl pyrophosphate (GGPP) provides the starting 
materials for the synthesis of the mono-, sesqui- and diterpenes 
respectively. Geranyl pyrophosphate is also the starting point for the 
synthesis of steroids and triterpenes because squalene, their precursor, is 
produced by a head to head coupling of two units off GPP. 
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Considering the almost unlimited possibilities for cyclisations and 
rearrangements of these terpene precursors it is little wonder that the 
terpenes are the most abundant and widely distributed group of natural 
products found in plants? 
0 
.,,,1l S-CoA ... 
acetyl coenzyme A 
( monoterpenes ) 
... 
~OPP -- ~OPP 
IPP DMAPP 
OPP 
n=2 
( sesquiterpenes) ( di terpenes ) 
Fig. 1.2 
One characteristic of cellular primary /intermediary metabolism is 
that it is achieved with relatively low steady-state concentrations of 
metabolites. Primary metabolites may sometimes be accumulated in an 
organism, but it is the exception rather than the rule. Secondary 
metabolism, on the other hand, is most often characterised by 
accumulation of metabolites in particular organs or tissues. This property 
is of course the reason why Man has used many of these compounds in 
differing parts of his existence (social, economic, recreational etc.). 
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Examples are many but three are worth mentioning.2 Mutants of 
Penicillium chrysogenum have been developed which produce 
penicillin G 1.6 in up to 20 g/L of the fermentation broth. Quinine 1. 7 
constitutes up to 10°/o of the dry weight of bark from trees of several 
Cinchona sp. and one of the worlds most important legal stimulants, 
caffeine 1.8, is found in up to 5-6°/o in coffee beans(Coffea sp) and the tea 
plant, Camellia sinensis. 
penicillin G 1.6 
0 
I 
N )) 
N 
'-.....N 
0~ 
I quinine 1.7 
caffeine 1.8 
Finally there is ample evidence that secondary metabolites play a 
significant role in a plant's interaction with its environment. This 
phenomenon is called allelopathy8,9,10, a term coined by H. Molish in 
1937 to describe "the biochemical interaction, both inhibitory and 
stimulatory, between all types of plants including microorganisms"ll. In 
indigenous plant communities, secondary metabolites from particular 
plants often affect the growth of other plants in the same area. This is 
exemplified by Adenostoma fasciculatum, a shrub found on the 
chaparral in California. Few other plant species can grow under the 
mature bush and the leachate of the leaves, containing high levels of 
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p-coumaric acid 1.9, ferulic acid 1.10 and p-hydroxybenzoic acid 1.11, 
inhibits the germination of seeds in several bioassays.12 
MeO 
HO HO 
1.9 1.10 1.11 
The same phenomenon is found near aromatic shrubs such as 
Salvia leucophylla, and the effect is caused by release of volatilised 
camphor 1.12 and 1,8-cineole 1.13 from the leaves. Zones extending 
beyond the canopy of these shrubs are devoid of other plants.13 
0 
camphor 1.12 1,8-cineole 1.13 
Interactions like these are not limited to plant-plant interactions. In 
terrestrial ecosystems several interactions between plants, insects and 
animals have been identified. Many plants contain natural products, 
mainly terpenoids and polyphenolics, which act as anti-feedants toward 
insects and herbivorous animals. The buds of balsam poplar,Populus 
balsam if era iare protected from the snowshoe hare because of its content 
of cineole 1.13, ( + )-a-bisabolol 1.14 and salicortin 1.15. During feeding the 
latter is hydrolysed to 6-hydroxycyclohexenone 1.16, which is the major 
antifeedant.14 
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Similarly the diterpene rhodojaponin III 1.17 has been found to be a 
potent antifeedant to the larvae of the Colorado beetle, Leptinotarsa 
decemlineata.15 On the other hand some animals have adapted to enable 
them to feed on tannin rich plants which are unpalatable to most other 
species. It has been found that mammals like koalas and other 
marsupials secrete high levels of PR (praline-rich) proteins with their 
saliva.16 These PR proteins have a high affinity for tannins thus 
rendering them more palatable or easier to digest.17 
Insects are known to sequester toxic compounds from their plant 
diet for use as deterrents towards predation by birds and other animals. 
The sequestered compounds may be used unchanged but in many cases 
they are modified by the insect. The larvae of the cinnabar moth is 
known to hydrolyse esters of retronecine 1.18 and re-esterify with necic 
acid produced by the insect to give callimorphine 1.19. In some moths 
retronecine is processed further to 7-(R)-hydroxydanaidal 1.20 a 
pheromone in the male moth>Creanotos transiens.18 
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0 
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This production of pheromones, used for communication 
particularly amongst insects, constitute another major use for secondary 
metabolites. When injured several pine species release verbenone 1.21, 
an anti-aggregation pheromone in the pine shoot beetle, Tomicus 
piniperda, which then avoids landing at that site.19 Another example is 
the effect the simple ketones (E)-3-heptene-2,5-dione 1.22 and (E)-3-
nonene-2,5-dione 1.23 have on honey bees. When the fire bee,Trigona 
mellicolor) raids a honey bee nest they release a mixture of these ketones 
rendering the honey bees completely inactive.20 
0 
0 
Verbenone 1.21 
0 
n = 11.22 
n = 31.23 
So why are secondary metabolites produced? Several theories have 
been proposed over the years. These include: a shunt or overflow 
mechanism for byproducts of primary metabolism; a detoxification 
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mechanism; arbitrary mutation resulting in derailment of metabolism to 
mention but a few.2 
The accumulation of secondary metabolites (vide supra) in some 
cases could be seen as support for the shunt mechanism. Nevertheless it 
would be dangerous simply to assume that because they often 
accumulate, all secondary metabolites are metabolically inert storage 
products. There is ample evidence that the turnover of some of these 
compounds 1s as high as their formation and occurring 
simultaneously.21 The shunt theory also fails to explain why most 
secondary metabolites show such a wide array of biological activity. A 
more recent theory is that what we are seeing is evolution in progress.22 
The examples in this chapter all support this view, and the terpenoid 
biosynthetic pathway (vide supra) provides one of the most versatile 
routes to structurally different compounds, capable of transmitting 
information on all levels of biological organisation. The fact that 
secondary metabolites are most abundant in less developed organisms, 
generally lacking an immune system, and are very seldom found 1n 
mammals or other higher organisms which possess some kind of 
immune system, supports the view that secondary metabolites have 
developed to improve the evolutionary fitness of the producer, either by 
showing an adverse effect on a competitor or by engaging a second 
organism in an activity which is advantageous to the producer.23 
If in fact secondary metabolism is an evolutionary process, the secondary 
metabolism we are studying today may not give us any information 
about its origin. The short time chemists have been studying secondary 
metabolites is but a blink of the eye on the evolutionary time scale. 
L 
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Pharmacognosy 
Mankind's attempts to relieve and cure diseases has followed an 
evolutionary path of trial and error using whatever means were 
available. Plant based treatments in particular have been utilised for this 
purpose. Because of the exploding population and the concurrent 
economic development, the demand for non-renewable energy, 
disposable consumer products, drugs, insecticides etc. will continue to 
increase for the foreseeable future. When one holds that against the fact 
that at no time in the history of humankind has the biodiversity on this 
planet been so low and rapidly disappearing, it is incomprehensible that 
so comparatively little is being done to search for useful products derived 
from these dwindling natural resources. 
Pharmacognosy, or the study of biologically active natural products 
has drifted in and out of popularity. The term is derived from the Greek 
words "pharmakon" meaning drug, "co" meaning intense and "gnosia" 
meaning knowledge of, and was coined at the beginning of the 19th 
century. It can be paraphrased as a thorough knowledge of drugs, and 
since the word was invented when drugs came from natural sources, it 
infers knowledge of natural drugs and their sources. 
The Western pharmacognostical tradition probably has its foundation in 
the civilisations of the ancient Middle East, where the earliest written 
records of the use of plants as medicinal agents dates back to Sumerian 
clay tablets from about 2100 BCl. The use of herbal medicine in ancient 
Egypt is also well documented in the Ebers Papyrus24 written about 1500 
BC. The Ebers Papyrus is the first written documentation of the use of 
willow (Salix sp.) as an antipyretic. The effect of willow extracts is due to 
its content of salicin 1.24, which is converted in vivo to the active 
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compound salicylic acid. To this day it is probably the most widely used 
analgesic in the form of synthetic acetyl salicylic acid or Aspirin™. Beside 
the analgesic and antipyretic activity it also has antiinflammatory 
activity. 
salicin 1.24 
The Western pharmacopoeias were however preceded by a 
systematic study of herbal medicine made by the Chinese emperor Shen 
Nung (ca .. 3000 BC.). Among the 365 different plants described in his 
treatise are: Ephedra sp. used for bronchial problems; Ricinus 
communalis used as a purgative; and the opium poppy Papaver 
somniferum. Today we know that these plants are the source of the 
clinically useful bronchodilator ephedrine 1.25, castor oil and morphine 
1.26 respectively. 
OH 
NHMe 
(-)-ephedrine 1.25 morphine 1.26 
Every maJor civilisation has employed plants as their primary 
source of medicine. As cultural interactions increased, the knowledge of 
medicine and the use of plants was transferred mainly through traders, 
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priests and explorers who journeyed from Europe to Asia and other 
places. Eventually the expeditions to North and South America, Africa, 
the Near and Far east and the Pacific Region were accompanied by official 
botanists who began recording some of this information. Unfortunately 
it is impossible to know how comprehensive these records were, so a lot 
of information about original medicinal agents might have been lost. 
Examples of drugs25 derived from plants which are still used around the 
world as medicines or poisons are: scopolamine 1.27 from mandrake, 
Mandragora officinarum, and henbane,Hyoscyamus niger; tubocurarine 
1.28, a muscle relaxant, from a South American lian
1
Chondrodendron 
tomentosum; physostigmine 1.29, a CNS stimulant, from the Calabar 
bean,Physostigma venenosum, used as an ordeal poison in West Africa; 
ergotamine 1.30 from ergot,Claviceps purpurea, the fungus that infects 
rye; and digitoxin 1.31, a cardiac glycoside, from digitalis Digitalis lanata. 
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The professional and academic interest in pharmacognosy has been 
declining in the last 50 years. In the 1930's and 1940's virtually every 
College and School of Pharmacy in the United States had a department of 
pharmacognosy or its equivalent. By mid-1985 only the University of 
Mississippi had a department bearing that name.25 Europe is in a similar 
situation with Britain having only one dedicated department of 
· pharmacognosy at the University of London.26 
In industry the situation is not much better. Several factors might 
have influenced the move away from using natural products as drug 
leads. The decline occurred at a time when organic synthesis was firmly 
established, the knowledge of biologically specific receptors was 
increasing and the concept of rational drug design developing. At the 
same time the pharmaceutical companies were increasingly investigating 
soil samples as sources ofJnicroorganisms producing bioactive 
compounds. Admittedly a host of new compounds have been found 
exhibiting a wide range of biological activity27 such as the antibacterial 
penicillin G 1.32 from Penicillium chrysogenum, antifungals like 
griseofulvin 1.33 from Penicillium griseofulvus, oxetanocine 1.34 an 
antiviral from Bacillus megatherium and antitumour compounds like 
mitomycin C 1.35 from Streptomyces verticillatus. 
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MeO 
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Why the interest in plant derived biologically active compounds 
waned in the three decade? after the second World War reaching a low in 
the 70's, is hard to understand when one considers such milestones as 
the discovery of reserpine 1.36 in 1952, the steroid hormones, e.g. 1.37, in 
1944-55 and vinblastine 1.38 in 1958. These compounds, all derived from 
plant sources, still form the base of today's most widely used drugs for the 
treatment of hypertension, birth control and cancer.25 
MeO 
0 
OMe 
0 
OMe 
OMe 
OMe 
Reserpine 1.36 
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N 
0 MeO 
progesterone 1.37 vinblastine 1.38 
What is the present status of pharmacognosy? In the last 10-15 years 
there has been an increased interest in products derived from 
natural sources which has not been limited to plant research. With the 
advent of new and more sensitive analytical techniques, the structure of 
several interesting compounds isolated in minute quantities from other 
sources. have been accomplished. Examples include: pheromones from 
the common honey bee,28 proteins from scorpion . venom used as 
molecular scaffolding29 and a new non opioid analgesic, epibatidine30 
1.39 from the skin of an Equadorian frog Epipedobates tricolor, 600 times 
more potent than morphine. 
Cl 
epiba ti dine 1.39 
Is it worthwhile to continue searching for new drugs derived from 
natural sources? There are several reasons for doing so. One reason is the 
position natural product derived compounds have amongst commercial 
drugs. Of the 25 best selling drugs of 1991, half were based on a natural 
product (Table 1.1)31. Another reason is nature's ability to synthesise 
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highly diverse compounds, some of which possess extremely selective 
biological activities. Looking at the structural diversity in the examples so 
far shown in this chapter 1.1-1.39 it is difficult to imagine a synthetic or 
medicinal chemist coming up with structures like these even with the 
aid of rational drug design and the knowledge of receptor binding 
geometry. 
Position Product Activity Sales 
1991 $m (US) 
1 Rani ti dine Hz-antagonist 3,032 
2 Enalapril • ACE inhibitor 1,745 
3 Captopril • ACE inhibitor 1,580 
4 Diclof enac • NSAID 1,185 
5 Atenolol P-antagonist 1,180 
6 Nifedipine CaZ+ antagonist 1,120 
7 Cimetidine Hz-antagonist 1,097 
8 Mevinolin• HMGCoA-R inhibitor 1,090 
9 Naproxen• NSAID 954 
10 Cefaclor• P-lactam antibiotic 935 
11 Diltiazem CaZ+ antagonist 912 
12 Flouxetine 5HT reuptake inhibitor 910 
13 Ciprofloxacin Quinolone 904 
14 Amlodipine CaZ+ antagonist 896 
15 Amoxycillin • P-lactam antibiotic 892 
16 Acyclovir Anti-herpetic 887 
17 Ceftriaxone • P-lactam antibiotic 870 
18 Omeprazole H+ -pump inhibitor 775 
19 Terfenadine Anti-histaminic 768 
20 Salbutamol • Pz-agonist 757 
21 Cyclosporin • Immunosuppressive 695 
22 Piroxicam • NSAID 680 
23 Famotidine Hz-antagonist 595 
24 Alprazolam Benzodiazepine 595 
25 Oestrogens• HRT 569 
Table 1.1 ( • natural product derived) 
Chapter one 17 
The most recent examples of natural products with prom1s1ng 
biological activity are artemisinin32,33 1.40 an antimalarial from the 
Chinese herbal drug quing hao Artemisia annua; forskolin34 ,35 1.41 a 
promising antihypertensive and cardiotonic agent; and the anti tumour 
compound taxol36,37 1.42a from Taxus brevifolia. The parent compounds 
themselves are interesting in their own right but it is more likely that 
structurally modified analogs will prove even more interesting, with 
more selective activities and less side effects. Currently considerable 
effort is being put into synthesising forskolin derivatives.38 
OH . ,,ij .. ,,, :;..,-"" 
0 
0 
artemisinine 1.40 Forskolin 1.41 
R1NH 0 PhvO .... · 
OH 
OR 
taxol 1.42a R= Ac, R1 = Bz 
taxotere™ 1.42b R= H, R1 = t-BOC 
The role of natural products as leads for new synthetic or 
semisynthetic drugs is not to be overlooked. In addition to the relatively 
few natural products which have found direct medical application there 
are a host of drugs where a bioactive natural product has served as a 
"template" for their development. Widely used drugs like the synthetic 
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antimalarials (chloroquine, mepacnne, primaquine), local anaesthetics 
(benzocaine, procaine, lidocaine), analgesics (propoxyphene, methadone, 
meperidine) and skeletal muscle relaxants (atracurium besylate) are based 
on the well known natural products quinine, cocaine, morphine and 
curare. Another twist to this theme is the fact that analogs of old drugs 
are found to exhibit new activities as in the case of ~ 9 _ 
tetrahydrocannabinol 1.43, the main psychoactive constituent of 
marijuana Cannabis sp. Synthetic analogs (e.g. nabilone) have been 
approved in the U.S. for the treatment of the nausea associated with 
cancer chemotherapy38,39 and various other disorders. 
~
9
-tetrahydrocannabinol 1.43 
A final reason why it is imperative that research into bioactive 
natural products should be intensified is the fact that the natural 
resources from which they are derived are dwindling faster than ever 
before. Considering that only an estimated 5-15°/o of the ca. 250,000 
known species of higher plants have been systematically surveyed for 
biologically active compounds40,41 and that a majority of these plants are 
found in the tropics, it is alarming to think about the hundreds or maybe 
even thousands of potentially interesting species which are becoming 
extinct every year because of the disappearance of the tropical rainforests. 
While there is agreement that the decrease in botanical diversity because 
of deforestation is detrimental, in statistical terms it is impossible to 
assess its full potential because the total number of species in the biome 
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(flora and fauna) 1s unknown. Recent estimates of the number of 
undescribed higher plants tends to converge around ca. 10,0QQ42, nearly 
all being tropical. Contrasted with the ca. 250,000 currently known species 
it makes plants one of the more widely studied groups of organisms on 
this planet. This is not the case however if one looks at fungi. A recent 
attempt to calculate fungal diversity came up with a lowest estimate of 
about 1.3 million, perhaps even as high as 13.5 million, as compared to 
the ca. 70,000 known species43. These surveys cover only terrestrial 
organisms. There is a reluctance to put a number on the diversity of 
marine organisms, particularly as the deep sea species are virtually 
unknown. Natural products research in the last 20 years has shown, 
however, that many marine organisms produce secondary metabolites 
different to the ones found in the terrestrial flora and fauna (e.g. 
peroxides, isonitriles, halides, isothiocyanates). 
Fortunately most multinational pharmaceutical companies (e.g. 
Merck, Glaxo, Hoechst) have now started screening programs of higher 
plants, in addition to the use of fermented microorganisms, as a source of 
new active compounds44. Some smaller companies like Xenova (UK), 
Shaman Pharmaceuticals (USA) and Natural Product Sciences (USA) are 
dedicated to finding biologically active natural products. As the name 
implies (shaman meaning witchdoctor or healer in the languages of the 
North American indians) Shaman Pharmaceuticals strategy is to collect 
and evaluate ethnopharmacological information on the indigenous 
medicinal use of plants in certain therapeutic categories25 (vide infra) . 
Most of these companies have policies to address the ethical, financial 
and conservational issues associated with the use of indigenous 
knowledge. The majority of the multinational companies have to change 
their profit oriented attitude. I{)tead of just reaping the benefits derived 
from the knowledge, they have to compensate the indigenous 
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communities adequately. A final issue that needs to be addressed is the 
conservation or renewal of the plant sources containing the active 
compound, which is exemplified by the overharvesting of pacific yew 
trees in the early phases of the taxol 1.42a research. Because taxol is 
extracted from the bark of the tree, the tree is destroyed in the process. 
Fortunately it was found that a precursor to taxol, baccatin III could be 
obtained in at least as high a yield from the needles of several yew 
species, thus providing a renewable source of starting material. All that 
needs to be done is to introduce the ~-amino acid sidechain, a fact that 
has led to a derivative of taxol, taxotere™ 1.42b, which is currently 
undergoing clinical trials in France for the treatment of ovarian cancer. 
In cases like this researchers and drug producers have an obligation to act 
in a responsible manner. 
In the last few years work has progressed toward world agreement 
on legislation and codes of conduct pertaining to the an environmentally 
neutral utilisation of the natural resources on this planet. Initiated with 
the Biodiversity Declaration at the Rio summit and the Manila 
Agreement46 in 1992 it has since been elaborated on and ratified in the 
Melaka Accord4~ 
One solution to the problems of shortage of natural sources might, 
in some cases, be alleviated by the use of modern biotechnology. Plant 
tissue cultures can in some cases be induced to produce secondary 
metabolites in vitro not normally found in the tissue in vivo.48,49 This is 
done by a genetic transformation of the plant tissue by treatment with 
bacteria like Agrobacterium tumefaciens. One example is the production 
of scopolamine 1.27, and atropine from cultures of hairy-roots of Atropa 
belladonna, in yields as high or higher than that obtained from plants 
grown in the field.so 
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Traditional medicine 
Traditional medicine has over the last decade begun to receive 
serious attention from scientists around the world, and the reasons for 
this will be examined in this section. 
Traditional medicine reaches different levels of sophistication depending 
on the cultural level of the society using it. In primitive societies a large 
number of remedies rely heavily on magic and superstition as well as 
"real" medicines. An example of this is for a rheumatoid patient to carry 
a potato in his pocket. As the potato looses water and shrinks, so is the 
rheumatic pain supposed to diminish. Another "less" scientific approach 
which was particularly favoured in the Middle Ages is the so-called 
Doctrine of Signatures.51 According to this doctrine the use of a plant 
could be deduced from its appearance. Accordingly liverwort (Pellia sp.) 
was used against diseases of the · liver because of its liver shaped thallus. 
Lungwort (Pulmonaria sp.), because of its mottled leaves was supposed to 
cure lung problems and the Adder's Tongue Fern (Ophioglossum sp.) as 
the name implies was used against snake bite. 
Through thousands of years of trial and error a large number of effective 
remedies have evolved. If this information can be collected and 
catalogued before it is too late the benefits can be reaped in the form of 
new bioactive compounds. The effectiveness of this natural selection 
process is shown by the fact that the use of the corkwood Dyboisia 
myoporoides in New Caledonia to treat ciguatera poisoning parallels 
one of the first modern treatments of the poisoning.52 It was suggested 
that a mixture of pyridinium aldoxime methiodide (PAM) 1.44 and 
atropine 1.45 might be effective. A subsequent investigation of a water 
extract of Dyboisia myoporoides revealed a high concentration of 
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nicotine 1.46 and scopolamine 1.27 two compounds structurally related to 
the ones suggested for clinical use. 
PAM 1.44 
nicotine 1.46 
atropine 1.45 
/ 
N 
Another striking example is the comparison of plants traditionally 
used in Europe, East Asia, South Asia and East Africa to treat people 
infected with tapeworms. They all contain surprisingly similar 
phloroglucinol based anthelmintic constituents53 (Fig. 1.3). 
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Even animals are known to use plants to treat ailments. Chimpanzees 
have been observed to eat a particular plant when they are infected with 
nematodes. The leaves are rolled to a ball and swallowed whole without 
chewing.54 The fact that the leaves are swallowed without being chewed 
suggests that they serve a different purpose than the normal food plants. 
A statistical analysis of the efficiency of using ethnopharmacological 
information for directing research into bioactive compounds is scarce. 
However the data from the screening for anticancer compounds by the 
NCI (vide supra) was analysed by Spjut and Perdue55 (Table 1.2). Of all the 
plants collected 10°/o showed some activity either in vitro or in vivo. 
Subsequent classification of the total number of plants into groups of 
known uses, or activities, shows that the number of hits increase in the 
groups with a known use. 
Plant types 0/o active• no. screened 
Plant collected at random 10.4 2127 
Plants used against cancer 19.9 226 
An thelmin tics 29.3 482 
Fish poisons 38.6 145 
Plants poisonous to man 50.0 129 
Arrow poisons 52.2 46 
Table 1.2 
The preceding three examples show that traditional medicine can be 
a powerful source of information for the natural products chemist 
searching for biologically active compounds. Random collections should 
not be abandoned though, since biologically active compounds are still 
found in plants which have never been described as having any known 
activity. For shorter term projects however using ethnobotanical 
1: 
l 
Chapter one 24 
information for collection can significantly increase the chance of finding 
bioactive compounds. 
For the work presented in this thesis the plant material was selected 
mainly using ethnobotanical information about their use among 
aboriginal communities in the northern and central parts of Australia. 
CHAPTER TWO 
METHODOLOGY 
I 
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Methodology 
The search for new drugs from plants necessarily needs to 
encompass a number of different disciplines. People with different kinds 
of skills are needed to complete a full investigation; botanists and 
taxonomists to collect and identify the different plant species chosen for a 
given project; pharmacologists to assess the biological activity; and 
chemists to do the isolation, purification and structure determination of 
the active principles. 
Plant selection 
The five most widely used approaches to plant selection can be 
classified under the following headings: totally random, taxonomic, 
chemotaxonomic, information. based and ethnopharmacological/ 
ethnomedical. These approaches can be used alone or in combination as 
a way of selecting plants for a project. 
In the totally random approach, all available species are collected 
regardless of knowledge of any biological activity of the plant. This is the 
approach the National Cancer Institute took in their worldwide 
collection and evaluation of plants as a source of new anticancer 
compounds between 1960-1976.56 A number of new compounds were 
found, the most notable examples being the discovery of the bisindole 
alkaloids (vinblastine, vincristine etc.) from Catharanthus roseus and, of 
course, taxol. The NCI is currently running a similar project with the 
emphasis on plants from tropical rainforests.57 
In the taxonomic approach one or several taxa are selected because 
members of the taxa have previously shown some activity. Plants from 
these taxa are then collected from many different locations around the 
Ir 
i 
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world. In the chemotaxonomic approach a particular compound class 
considered to be of interest, e.g. pyrrolizidine alkaloids, is targeted and 
plants thought likely to contain such compounds are collected from a 
variety of locations. In the information-based approach plants of proven 
biological activity (e.g. poisonous to livestock) which are unlikely to 
contain known active agents are collected in the hope that they will yield 
novel compounds. 
In the ethnomedical/ ethnopharmacological approach, selection is guided 
by the oral or written information about the medicinal use of plants as 
described in the previous chapter. Based on a thorough evaluation of this 
information, the plant is then collected. A sixth "approach" is 
serendipity, where collection of a plant based on an ethnomedical use 
leads to the discovery of a different activity to the one claimed in the 
plant folklore. The discovery of the Catharanthus alkaloids again is a 
good example since the traditional medicinal use of the plant was as a 
treatment for diabetes. 
Unfortunately, information about the use of plants amongst many 
indigenous minorities around the world is being lost because of their 
contact with civilisation and the subsequent introduction of modern 
medicine into these societies. It is of the utmost importance that this 
kind of knowledge is collected and preserved before it is lost forever. A 
variation on the ethnomedical/ ethnopharmacological approach is the 
use of information provided on labels on plant specimens in herbaria. 
The herbaria around the world contain millions of specimens collected 
over the last 200 years or so. Since most of the early collectors were 
taxonomists rather than ethnobotanists, the information on the labels 
usually reflect this. Even though a lot of information has probably been 
missed there is still an abundance of notes providing some information 
about medicinal uses of the plant. In the late sixties one ethnobotanist, 
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Siri von Reis Altschul, realised this and in the following 20 years she 
undertook the enormous task of sifting through the collection notes in 
the herbaria at Harvard University58 and the New York Botanical Garden 
Herbarium,59 excluding plants previously catalogued in other compendia 
as having medicinal uses. 
Isolation and separation 
In the following sections the various techniques available for 
isolation, separation and purification of biologically active metabolites 
are considered. While in the process of isolating and identifying the 
substance(s) responsible for the bioactivity observed, there is a question of 
balance involved. The identification of the compound is not more 
important than ensuring that it is pure and properly characterised. An 
illustrative example is described by Nakanishi.60 In 1975 the structure of 
azadirachtin 2.1, a potent insect antifeedant, was proposed by Nakanishi 
and coworkers. 
i=\ 0 . 
H 
azadirachtin 2.1 
The structure was based mostly on results obtained from a new 13C-
NMR technique and was not convincing. For about ten years the 
compound was used as a test sample for new NMR pulse sequences in 
attempts to obtain more evidence for the structure, but little progress was 
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made because of the lack of pure material. This continued until 1986 
when a new isolation scheme was devised61 providing 10 g of pure 
material and, with this, the possibility of studying its chemistry. By the 
time the revised structure was proposed several other groups had arrived 
at the correct structure. 
Although isolation and purification are essential in any work on 
bioactive compounds, they represent the more tedious and time-
consuming aspect of natural product chemistry and, because an 
increasing number of compounds are being isolated, more and more 
often the result is the isolation of a known compound. While structure 
determination in many ways has become more routine, isolation and 
purification have not. This however is not apparent from most papers 
dealing with the isolation, purification and structure elucidation of 
natural products. While a large part of a paper will deal with the 
rationalisations behind the determination of a structure, the isolation 
and purification steps are accompanied by only a flow chart and a list of 
column supports and eluents used in the purification of the 
compound(s). The temptation to bypass careful isolation and purification 
processes is compounded by the fact that what might take weeks, 
sometimes even months, to accomplish in the laboratory will be 
described in one sentence in the experimental part of a paper. 
Various reviews and books dealing with isolation and purification 
exist,62,63,64 and the journal Phytochemical Analysis which is dedicated 
to publishing articles "on the application of analytical methodology in 
the plant sciences"65 has interesting articles, which help to take the 
guesswork out of the isolation/purification procedure. 
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Extraction 
Before an extraction is initiated several things have to be 
considered 66. Firstly - what is the nature of the plant material (roots, 
heartwood, foliage)? Secondly - is it contaminated with other plant 
material? If so it has to be freed of the contamination. Thirdly - is it free 
of diseases? That is, not affected by viral, bacterial or fungal infections. 
Infected samples have to be discarded since products of microbial 
synthesis may be detected in the plant tissue and infections might alter 
plant metabolism to an extent where unexpected compounds are 
produced, possibly in large amounts. These problems are not limited to 
plant material. When collecting fungi or mosses growing on trees, all the 
tree tissue has to be removed from the fungus before extraction in order 
to eliminate the isolation of compounds associated with the 
contaminating tissue. 
Because of the relatively large volumes used it is obvious that only 
pure solvents be used, minimising the accumulation of contaminants 
from the solvents. Good commercial solvents, glass distilled once, are 
usually sufficiently pure. Less obvious is the fact that extractions should 
be carried out under as mild conditions as possible, using, if possible 
solvents of low reactivity in order to minimise the formation of artefacts. 
The form that the biological material is in prior to extraction greatly 
influences the choice of solvent(s). Dry material is usually extracted with 
a variety of solvents, often sequentially from low to high polarity (e.g. 
heptane, dichloromethane, ethyl acetate, methanol) resulting in a crude 
fractionation of metabolites. Another way is to use a polar solvent like 
ethyl acetate or methanol and leave the separation to a later 
chromatographic step. The choice of solvent can also determine, to some 
extent, whether exo- or endocellular metabolites are extracted.67 With dry 
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material, ethyl acetate and low polarity solvents only rinse or leach the 
sample, whereas alcoholic solvents are presumed to rupture the cell 
membranes and extract a greater amount of endocellular material. A 
good all round solvent mixture is 1:1 dichloromethane/methanol. This 
mixture is the solvent of choice when extracting fresh material. Because 
of the relatively high water content it can be difficult to wet the sample 
with apolar solvents like heptane, even when macerated. For small 
quantities of fresh material freezing in liquid nitrogen is convenient. The 
frozen material can then be ground and extracted in the normal way. 
Liquid culture broths and other biological fluids can be extracted with 
solvents of increasing polarity from heptane to butanol. The pH of the 
medium can greatly influence the efficiency of the extraction and 
extraction at varying pH will ensure maximum recovery of extract and 
may lead to partial fractionation. One method of extraction which has 
attracted a lot of interest in r~cent years is supercritical fluid (SCF) 
extraction68. Although it is still in the development phase it offers some 
advantages over conventional extraction techniques. Some of the 
advantages are that it is fast, the gases used (e.g. CO2) are usually inert, 
and the solvent strength can be controlled by varying the pressure and by 
adding small amounts of a co-solvent such as methanol or water. 
Examples of the use of SCF in the isolation of natural products have 
appeared69,70 but the main disadvantages of the technique are the use of 
pressure equipment and the high instrumental cost. 
Because many extracts contain significant amounts of fatty material 
that can interfere with subsequent chromatographic separation it is 
usually beneficial to remove this by partitioning of the extract before any 
separation is attempted.71 The extract is dissolved in a 1:1 mixture of 
heptane-methanol and enough water is added to give two phases which 
are then separated. Another simple cleanup step which simplifies further 
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separation is precipitation. When a concentrated methanol extract is 
added to a large volume of ether, saponins and some other glucosides are 
precipitated.72 The precipitate is then collected by filtration or 
centrifugation. The precipitation can be repeated several times to effect a 
simple fractionation of the extract. 
Purification 
The separation of one or more bioactive substances from a crude 
extract can be a long and expensive process, and isolation of a pure 
compound often requires several separation steps involving different 
techniques. A host of chromatographic techniques have been developed 
and implemented in the separation of natural products, since M. S. 
Tswett separated leaf pigments on a column of precipitated calcium 
carbonate in 1906.73 Most of .these methods have been thoroughly 
reviewed. They include flash column chromatography74, thin layer 
chromatography (TLC)75, preparative thin layer chromatography 
(PTLC)76, medium pressure liquid chromatography (MPLC)77, high 
performance liquid chromatography (HPLC)78,79, and gel filtration80,816 
and most books about general laboratory practices have descriptions of 
the use of these methods. One book, by Hostettman, Hostettman and 
Marston82, describing the most widely used preparative chromatographic 
techniques, is particularly useful because of the large number of tabulated 
examples it contains. A wide range of natural product classes are covered 
making it easier to choose stationary phases and solvent systems for a 
given separation. 
Three chromatographic techniques deserve special attention. 
Centrifugal thin-layer chromatography (CTLC)82 is gaining popularity 
over preparative thin layer chromatography, particularly in the form of 
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the Chromatotron™. Plates are as easy to make as PTLC plates and they 
can be regenerated and used repeatedly unlike PTLC plates. Separation 
times are short, usually around 30 min and the amount of solvent used 
is less than for the same separation on a flash column. The only 
disadvantages of this technique is the cost of the equipment and the 
restricted choice of stationary phases. 
Another simple, but underused, technique is vacuum liquid 
chromatography (VLC).83,84,85 It has been used mainly with silica and 
alumina as stationary phases but it has been adapted to reverse phase 
chromatography as well.86 All that is needed is standard laboratory 
glassware. An appropriately sized sintered glass funnel is packed about 
2/3 full of dry packing material according to Pelletier84 and pre-washed 
with a low polarity solvent or solvent mixture to wet the packing 
material. The sample is then loaded on the column either as a solution 
or more commonly by evaporating a solution of the sample with Celite 
and spreading the resulting powder on top of the packing material. 
Because of the weakly adsorbing properties of Celite, the sample can be 
loaded onto the chromatographic packing as a very narrow band by 
elution with a low polarity solvent before the real separation is 
commenced. The separation is then carried out by adding a fixed volume 
of solvent, depending on the size of the column, and sucking the column 
completely dry between fractions. VLC has several advantages over flash 
column chromatography when separating crude plant extracts. Crude 
extracts are rarely soluble in the solvent system optimal for the 
separation and this problem is overcome by the loading of the sample as 
a solid. Because the VLC column is sucked completely dry between 
fractions it is ideal for gradient elution, and unlike flash column 
chromatography quite steep gradients can be used. Depending on the 
individual extract it is not uncommon to use gradients starting with 
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100°10 heptane or dichloromethane and ending with 100°10 ethyl acetate, 
within a total of 20-30 fractions . 
The last technique to be considered here is countercurrent 
chromatography82,87. Several techniques have been developed, such as 
droplet countercurrent chromatography (DCCC),88 rotation !ocular 
countercurrent chromatography (RLCCC)89 and high speed 
countercurrent chromatography (HSCCC).90 Of these DCCC is probably 
the most widespread. All countercurrent chromatography systems build 
on the same underlying principle, liquid-liquid partition. Because there 
is no solid stationary phase it is complementary to most other 
chromatographic methods and it makes it eminently suited to the 
separation of compounds which adsorb irreversibly to solid supports. 
This is exemplified in the separation of a crude mixture of pyrrolizidine 
alkaloids.91 Because this class of alkaloids have a tendency to adsorb 
irreversibly to reverse phase supports as well as silica and alumina DCCC 
was chosen for the separation. Out of the ten closely related compounds 
in the mixture, eight were obtained pure with only a few mixed fractions 
in between. As an illustration of the kind of separation which can be 
achieved, small amounts of 2.2 and 2.3 from the above mixture were 
obtained in pure form, in addition to a larger mixed fraction. This is quite 
remarkable considering that the compounds differ only in double-bond 
geometry. 
H 
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In general countercurrent chromatography is well suited for 
separation of polar compounds which are not easily separated on silica or 
alumina and also for initial fractionation of crude mixtures and extracts 
which might ruin a reverse phase MPLC or HPLC column. One 
disadvantage of these systems, in particular DCCC, is that they are slow. 
The need to ensure efficient partitioning and proper droplet formation 
mean that flowrates have to be low and flowrates of 1-5 ml/h are not 
uncommon. 
Finally capillary electrophoresis, a technique which has been used 
extensively in the separation of biopolymers, has begun to make its way 
into natural products chemistry. It has been used successfully for chiral 
separations and it can be used semi-preparatively.92 
Arte£ acts 
When working on the isolation of natural products the formation 
of artefacts can never be discounted. Artefacts can be introduced at any 
step from collection to extraction and purification. Even at the structure 
elucidation step artefacts can be formed. One of the most common 
artefacts encountered is the introduction of "unnatural products". Most 
natural product chemists working on the milligram scale have "isolated" 
plasticisers in the form of phthalic acid or dialkyl phthalates. Plasticisers 
are usually picked up from solvents and plants stored in plastic bags for 
extended periods, but another source could be accumulation from 
exposure to plasticisers in the environment. 2,6-di-tert-butyl-p-
hydroxytoluene (BHT) is also a common artefact since it is used as a 
stabiliser in diethyl ether and tetrahydrofuran. The presence of these 
compounds in solvents emphasises the need to use only distilled 
solvents for extraction and purification. The extraction procedure itself 
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can introduce artefacts, particularly when using chemically reactive 
solvents. Glycols can form acetonides on extraction with acetone and 
ketones can form acetals with alcohols. Another example is the conjugate 
addition of methanol to the iridoid glycoside 2.4 resulting in the 
rearranged product 2.S.93 
CHO 
.. .. 
OGlu 
2.4 
CHO 
0 
OGlu 
2.5 
OMe 
Simple changes like formation of esters when extracting with 
alcohols94 and formation of amides from esters on con~act with aqueous 
ammonia95 has also been observed. 
Organic solvents can be removed at, or below, room temperature by 
evaporation under vacuum but aqueous solutions are more difficult to 
concentrate without raising the temperature. To avoid unnecessary 
heating, freeze-drying or lyophylisation of aqueous extracts should be 
considered when possible, in order to prevent decomposition and 
chemical reactions occurring. 
Problems may also arise during the purification of extracts on 
chromatographic supports, particularly when active alumina is used.96 A 
range of reactions are known to be catalysed by alumina97 and in some 
cases{silica. 98 
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Bioassays 
Simple assays 
When performing bioassay guided fractionation of plant extracts, 
several things have to be considered. These include the choice of 
bioassay, the number of assays and the sophistication of the assays. Many 
factors can complicate a bioassay guided fractionation, the most obvious 
being that of solubility. Since most biological assays are conducted in 
aqueous or aqueous buffer systems and many plant extracts are lipophilic 
or of medium polarity, it can be difficult to get them in solution. This 
presents a problem since it is necessary to have an idea of the 
concentration in order for the assay to be meaningful. Several solutions 
to this problem have been suggested, such as coprecipitation with 
polyvinylpyrrolidone99, use of co-solvents like DMSQlOO and the use of 
surfactants67 to aid in solubilising the extracts. Another problem 
sometimes encountered is variation of the bioactivity at different stages 
of the purification. Usually the activity of extracts increases with purity 
but sometimes the activity decreases or it may disappear completely. 
There are several reasons why this might happen. A crude extract is 
almost invariably a complex mixture of different compounds and 
synergistic effects can increase activity. Also chemical changes during the 
purification can affect the activity and might result in a completely 
inactive compound. Finally it is well known that activity is dose 
dependant, which is why assays should be run at different concentrations 
in order to minimise the possibility of missing an active compound. 
There are certain features a front-line screening bioassay should possess. 
It must be rapid, convenient, inexpensive, sensitive and be able to pick 
up a range of activities. It should also be simple so chemists and botanists 
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can perform them without special training. These "bench-top" bioassays 
include: classical agar diffusion assays (antibiotic activity); brine shrimp 
lethality (cytotoxic activity); crown gall tumor inhibition (anticancer 
activity); and frond proliferation of duckweed (herbicidal and growth 
stimulant activity), to name the most widely used. 
Bioassays for detecting antibiotic activity are usually based on 
different agar diffusion techniques.101, 102 The simplest and most 
convenient method is the paper disc diffusion assay103. Different 
concentrations of an extract are applied to 5 mm filter paper discs. When 
the solvent has been completely removed by drying, the discs are placed 
in a petri dish or/.he surface of a layer of agar uniformly inoculated with 
a pathogenic organism. After incubation, usually overnight, inhibition of 
the organism shows up as clear zones around the paper discs. The size of 
the zone is related to the magnitude of the activity but cannot be 
compared readily because different classes of compounds diffuse at 
different rates. 
Paper disc diffusion assay 
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A variation, termed bioautography, is particularly useful during the 
purification of extracts. The extract is analysed by TLC and the developed 
TLC plate, after drying, is inverted and placed on an agar plate as 
described above. The compounds present as spots on the TLC plate are 
then allowed to diffuse into the agar for some time, the TLC plate is 
removed and the agar plate incubated as above. This is useful since 
specific spots showing activity can be identified thus saving time assaying 
all fractions coming off a column.104,105 
Typical organisms used in these assays are Bacillus subtilis and 
Staphylococcus aureus representing the Gram positives; Escherichia coli, 
Klebsiella pneumoniae and Pseudomonas aeruginosa of the Gram 
negatives; Candida albicans, and Saccharomyces carlsbergensis 
representing yeasts and fungi. 
The brine shrimp lethality test106 is simple and cheap to use. Brine 
shrimp Artemia salina, also known as "sea monkeys", are tiny 
crustaceans used as live food in aquaria, and are easily cultivated from 
the dried eggs obtained from pet shops. Extracts are tested at three 
different concentrations and the LCso at the 95°/o confidence interval is 
calculated using a statistics program on a PC. The brine shrimp lethality 
test appears capable of detecting a broad spectrum of bioactivities present 
in crude extracts and there appears to be a positive correlation between 
this assay and the 3PS in vivo murine leukemia antitumor assay 
(P388).107 
The crown gall tumor inhibition assay108 relies on the inhibition of 
tumors induced by Agrobacterium tumefaciens on discs cut from 
potatoes. This assay shows an even better correlation with the 3PS assay. 
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One prerequisite for this test, however, is that the extract being tested 
does not show antibacterial activity toward A. tumefaciens. 
The last example of the simple assays is the use of duckweed Lemna 
minor to screen for herbicidal or plant growth stimulant activity.107 The 
test is performed much like the brine shrimp assay at three initial 
concentrations, with the results being analysed statistically. 
Specialised assays 
In addition to the "bench-top" assays an array of specialised assays is 
available.109 These assays are usually targeted at a specific activity such as 
cytotoxicity against a specific cancer cell line; antimalarial activity and 
insecticidal activity against selected insects. They are usually not readily 
available to the natural product chemist because of their sophistication 
and the expertise required of the people performing them. 
Since the simple assays pick up a range of activities, once a bioactive 
compound has been isolated, it can be tested in the specialised assays to 
probe the specificity and the magnitude of the activity. 
Structure elucidation 
Natural product chemists each have their own approach to 
determining the structure of a new compound, depending on their 
personal preference in analytical techniques. Analytical techniques 
provide information which can help in putting together the pieces of the 
puzzle leading to the final structure. UV-VIS and IR-spectroscopy have 
been extensively reviewedll0,111 and can provide useful information on 
chromophores and distinct functional groups in a molecule. The most 
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powerful methods today, however, are mass spectrometry (MS),112,113 
nuclear magnetic resonance (NMR)ll4,115 and, if suitable crystals can be 
grown, X-ray crystallography.116,117 Today few derivatisation or 
degradation experiments are required to solve the structure of a natural 
product, al though they can be useful. 
Mass spectrometry 
Mass spectrometry is commonly used to provide the molecular 
mass of unknown compounds. Additionally, if an accurate mass 
measurement is carried out on the molecular ion, its molecular formula 
can be derived. Because of the inherent properties of electron impact 
mass spectrometry, i.e. ionisation and fragmentation, structural 
information is obtained which in conjunction with other information 
usually leads to complete structures. Mass spectrometry has several 
advantages over other techniques in that it requires very little material, 
and molecular mass information can often be obtained even from 
impure samples. The choice of ionisation method used depends very 
an d 
much on the polarity J thermal stability of of the sample. Electron impact 
ionisation (EI)ll8,119 and chemical ionisation (CI)120 are the most 
common and are complementary. CI provides information on molecular 
mass and EI because of its "harder" ionisation and resulting 
fragmentation provides more structural information. MS information 
on polyphenolics, glycosides, and other polar compounds, which are 
either involatile or too labile to yield a molecular ion under standard MS 
conditions, can usually be obtained using fast atom bombardment 
(FAB)121 ionisation. The molecular mass of biopolymers can be obtained 
through electrospray ionisation122 or MALDI (Matrix Assisted Laser 
Desorbtion Ionisation). EIMS can also be a quick method for identifying 
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known natural products. The fragmentation information contained 1n 
the EI mass spectrum provides a "fingerprint" of the compound which 
can be computer matched against the mass spectra of known compounds 
in the extensive databases of mass spectral data available,123 facilitating 
the identification of the compound. 
NMR-spectroscopy 
Even though mass spectrometry can provide information on 
structural fragments, the most powerful tool for establishing a molecular 
framework is NMR spectroscopy. The power of NMR lies in the fact that 
not only does it define the number and type of atomic nuclei in an 
organic molecule, but it also describes the chemical environment and the 
interconnection of these atoms. Today many multi-pulse experiments 
have been developed. Most . of these, however, are specialised 
experiments and only a small proportion are regularly used for 
elucidation of molecular structure. Several texts dealing with the 
interpretation of routine 1 H and 13C spectra have been 
published,110,111,124 but for complex structures simple one dimensional 
spectra are usually difficult to interpret because of overlapping proton 
signals. This problem can usually be overcome by using different 
decoupling experiments and 2D experiments. Selective decoupling is 
however problematic if proton signals are close together and 
overlapping. Recording the spectrum at a higher magnetic field strength 
(e.g. 600 or 750 MHz) can improve separation of the signals if 
instruments are available. COSY (in particular double quantum filtered 
COSY, DQF-COSY)125 and TOCSY (TOtal Correlation SpectroscopY)l26 
experiments are powerful methods for tracing spin-spin coupled protons 
within a molecule. By changing the delay in the TOCSY experiment all 
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protons within a spin system can be defined, even though some are not 
directly coupled. Similar experiments have been developed for 
heteronuclear correlation and long range heteronuclear correlation most 
notably H,C-COSY or HETCOR127 and COLOC128 experiments. Sensitivity 
can be a problem in the heteronuclear correlation experiments and if 
only small amounts of material are available long experiment times are 
usually needed. This problem has been alleviated somewhat with the 
development of inverse detection experiments129 such as HMQC 
(Hetronuclear Multible-Quantum Coherence) and HMBC (Heteronuclear 
Mutible Bond Correlation). These rely on irradiation of the carbons but 
detection of the H,C coupling at the much more sensitive proton. Using 
the HMBC experiment a long range H,C correlated spectrum can be 
obtained on 1-5 mg of an organic sample in a few hours. Sensitivity is 
also the biggest problem with, what is probably the ultimate experiment 
for determining the carbon framework, the 20-INADEQUATE 
(Incredible Natural Abundance DoublE QUantum Transfer Experiment) 
sequence.130 Because it detects bonding between adjacent 13C-atoms it is a 
factor of 10-2 less sensitive than a normal 13C experiment. 
The relative stereochemistry of a compound can be probed using NOE 
experiments such as the NOE-difference131 or NOESY (Nuclear 
Overhauser Enhancement SpectroscopY)132 techniques. The NOE-
difference experiment suffers from the same problems as other 
decoupling experiments (vide supra), in addition to problems created by 
the subtraction of two spectra (e.g. noise and artefacts). New pulse 
sequences, which provide the same information with higher sensitivity, 
and eliminate subtraction of spectra, have been developed133 and these 
might eventually supersede the NOE-difference experiment. Recently it 
has been shown that combining the methods described in this section 
with the use of lanthanide induced shifts (LIS) the structure of a 
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sesquiterpene triol could be determined.134 This was not possible from 
the non-shifted spectra. 
Several texts describing modern pulse techniques124,125,135 are 
available but one book in particular, edited by K. Nakanishi, deserves 
mentioning.136 It has the form of a compendium listing all the major lD 
and 2D techniques along with their pulse sequences and examples of 
their use which makes it simpler to 
X-ray crystallography 
Sometimes, conventional chemical and spectroscopic methods fail 
to eliminate all possible structures consistent with the observed data. 
X-ray crystallography on the other hand provides an unequivocal 
determination of the three dimensional structure of a crystalline 
compound, even in the absence of physical and spectroscopic data.116,117 
As the name implies the compound to be analysed has to be 
crystalline and many non-crystalline compounds contain functional 
groups which can often be derivatised to give a crystalline compound. 
Crystals are usually grown by slow recrystallisation from low boiling 
solvents (e.g. methanol, ethyl acetate, hexane, toluene). The choice of 
solvent is primarily guided by the solubility of the sample. Sometimes it 
is advantageous to use a large volume of a solvent in which the sample 
is not very soluble. Slow evaporation of such solutions often result in 
well defined crystals. An alternative method for growing crystals of 
compounds that do not readily crystallise is the use of solvent pairs.137 
One problem obtaining crystallographic data is that even if crystals 
can be grown they may not be suitable. Ideally a crystal should be a perfect 
single crystal and often crystals have properties that interferes with the 
experiment (e.g. twinning, opacity). 
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One strength of X-ray crystallography is its ability to determine absolute 
stereochemistry by anomalous scattering methods.138,139 These methods 
are most useful for structures containing intense scattering entities (e.g. 
bromine, iodine and other heavy atoms) but absolute configurations 
have been established on structures containing no atoms heavier than 
oxygen.140 
Determination of absolute stereochemistry 
In addition to X-ray crystallography some other methods have been 
used to determine the absolute configuration of an organic compound 
such as Horeau's method,141,142 NMR of diastereomeric derivatives and 
the exciton chirality method. 
NMR of diastereomers formed on derivatisation with optically pure 
Masher's acid (MTPA) or (9-anthryl)-methoxy acetic acid is sometimes 
useful,143,144 particularly for secondary alcohols, and a set of empirical 
rules have been proposed to enable the determination of the absolute 
stereochemistry.145,146 LIS reagents can be used to increase the chemical 
shift differences.147 
The exciton chirality method is based on the interaction of the 
electric dipole of two chromophores and the resulting splitting of the 
corresponding CD-spectrum (circular dichroism).148,149 It was originally 
developed for two identical chromophores but can be extended to 
different chromophores provided the direction of the electric dipole is 
known. If the compound to be analysed lack suitable chromophores they 
can be introduced by derivatisation or complexation.150 Since the exciton 
chirality method relies on interaction of chromophores showing strong 
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UV absorption analysis can be carried out on very small amounts of 
sample. 
Dereplication of natural products 
Although screening natural product extracts for novel bioactive 
compounds has become an increasingly challenging area of research, it is 
becoming more and more difficult to find new compounds due to the 
vast number of known compounds already described in the literature. 
Because of this the rapid characterisation of known compounds, a process 
known as dereplication, has become an important part of natural product 
chemistry in order to minimise the timewasted on "rediscovering" a 
known compound. 
Several commercial databases have emerged in the last decade that 
can assist in reducing the time used to elucidate the structure of a known 
compound. The largest database by far is the Chemical Abstracts Registry 
File but other databases such as Chapman & Hall's Dictionary of Natural 
Products, NAPRALERT and the Marine Natural Products Database of 
which most can be searched using search engines like STN Express®. 
A review of some of these databases including examples of searches 
has recently been published.151 
CHAPTER THREE 
ANTIBIOTICS FROM AUSTRALIAN 
PLANTS 
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Introduction 
The work that will be discussed in the following sections involves 
the isolation, purification and structure elucidation of natural products 
from four plants and a fungus. 
Even though chemical studies of plants used in traditional medicine are 
becoming more common, in particular in South East Asia, comparatively 
few researchers have been interested in the herbal medicinal tradition of 
tribal aborigines in Australia. This might be due to the fact that 
Australian aborigines have a less developed, or documented, use of herbs 
and plants compared to other cultures, e.g. the Chinese, who have 
refined traditional medicine to a high level. In the last decade this has 
changed and a few compendiae have been published compiling 
information about the medicinal use of Australian plants gathered from 
old texts and other written material.152,153 One recent pharmacopoeia154 
is based on primary information gathered by interviewing aborigines in 
the northern and central parts of the Northern Territory rather than 
basing it on a literature search. 
Before selecting any plant material the type of bioassay used to guide 
the separation had to be established. It was decided to assay for antibiotic 
activity, using the paper disk agar diffusion assay, as described in Chapter 
Two, because the in house facilities were already in place. The organisms 
used for the assays were Bacillus subtilis (Gram positive), Escherichia coli 
(Gram negative) and Saccharomyces carlsbergensis (yeast). In addition 
Phytophtera cinnamomii (fungi) was used with some extracts. 
A list of plants described in references 1,2 and 3 as used by tribal 
aborigines to treat infections and wounds, that is, having antiseptic or 
antibiotic properties was compiled and several selected. These comprised 
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four plants, Pterocaulon serrulatum153, Lysiphyllum cunninghamii153, 
Capparis umbonatal53, Persoonia pinifolial54, and one fungus, 
Pycnoporus coccineus .154 
During the purification of extracts from C. umbonata the bioactivity 
disappeared. A recollection of fresh plant material was not possible and 
consequently work on C. umbonata was discontinued. 
Lysiphyllum cunninghamii 
Lysiphyllum cunninghamii of the family Caesalpiniaceae is a small 
tree found in open woodlands in the Darwin and Gulf regions of the 
Australian Northern Territory. A 30 cm piece of root or a 10x15 cm piece 
of bark is pounded well and boiled in 1 L of water and used by aborigines 
as a wash for skin sores and scabies. It is claimed to be more effective than 
anything available from European sources153 and with repeated use these 
skin complaints will reputedly clear up in a few days. 
Using bioassay guided separation of the extracts, one active 
flavanonol glycoside 3.1 was isolated. 
HO 
OH 0 
rAYOH 
... ,,,~OH 
3.1 
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This section will discuss the isolation and identification of (3.1) and 
the biosynthesis of flavonoids. 
Flavanonols belong to the large group of polyphenolic substances 
called flavonoids which are characterised by a C6-C3-C6 carbon skeleton. 
The flavonoids are almost invariably hydroxylated in the aromatic rings, 
<l~d 
most commonly in positions Si7 , which are the positions where 
oxygen was present in the acyclic acetogenic precursor before cyclisation 
(vide infra). Examples of compounds hydroxylated in all aromatic 
positions have been isolated,155 and often one or more of the hydroxyls 
are methylated. The major classes of flavonoids, and the numbering 
system are shown in Fig 3.1, without defining the stereochemistry at C2 
and c3.1S6,157 
HO 8 
Type R1 
Flavanone H 
Flavanonol OH 
Flavanol OH 
Flavone H 
Flavonol OH 
An thocyanidin OH 
0 
C 
3' 
R2 
C=O 
C=O 
CH2 
C=O 
C=O 
CH 
Fig 3.1 
I OH 
Other 
C2=C3 
C2=C3 
+01 =C2 , C3=C4 
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The flavonoids are mainly found as glycosides but they do exist as 
the free aglycones usually associated with secretory systems, essential oils 
and lipophilic secondary metabolites.158 Flavanones can undergo a two 
stage enzyme catalysed rearangement to isoflavones in which the C ring 
is attached to C3. 
In nature flavonoids play a significant role in protecting plants from 
being overeaten by herbivores and the red, blue and purple colors of 
fruits and flowers are due to their content of anthocyanidins.155 
Flavonoids show a wide range of biological activity including anti-
inflammatory, 159 antitumor,160 antimicrobial and antiviral 
activity .161, l 62,163 
More recently the high content of polyphenolics in wine (1-3 g/L in red 
wine) has been suggested to be responsible for the low frequence of 
arteriosclerosis in people from countries with a high consumption of 
wine.164 In particular the antioxidant properties of flavonoids have been 
shown to inhibit oxidation of low density lipoprotein (LDL), one of the 
contributing factors to arteriosclerosis. The most potent of the flavonoids 
tested, epicatechin 3.2 and quercetin 3.3, were significantly better 
antioxidants than the control a-tocopherol (vitamin E).165 
HO 
rAYOH 
... ,,,~OH 
··,, OH 
OH 
epicatechin 3.2 
HO 
OH 0 
quercetin 3.3 
OH 
OH 
Also worth noting is the renewed interest in soy products. Research has 
shown that women on soy rich diets are less likely to suffer from 
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osteoporosis and hormone related cancers, such as breastf:.ancer.166 It is 
thought that this effect is due to the high content of isoflavonoids in soy 
beans. Isoflavonoids are known to possess weak oestrogenic activity but 
because they are not real oestrogens they act as anti-oestrogens. Since the 
current treatment of hormone related cancers is with anti-oestrogens, 
supplementing the diet with soy products is thought to reduce the risk of 
developing cancer.167 
Isolation and structure elucidation 
Bark from L. cunninghamii was collected* in the Nitmiluk 
National Park, Katherine N.T. and a voucher specimen deposited at the 
Northern Territory Herbarium, Darwin. 
The dried bark was extracted with methanol and the extracts fractionated 
and purified according to scheme 3.1. 
Inspection of the NMR spectra suggested that 3.1 was a flavanonol 
glycoside. The negative FAB mass spectrum showed a prominent peak at 
m/z 449 (M-H)- corresponding to a molecular mass of 450 and a peak at 
m I z 303 for the loss of a deoxy-hexose unit. This was corroborated by 
peaks in the positive FAB mass spectrum at m I z 451 and 305. The EIMS 
showed a prominent ion for the aglycone at m I z 304 and a weak 
molecular ion peak at m I z 450. The base peak at m I z 153, with the 
composition C7H504 arising from a phloroglucinol acylium ion 
produced by a fragmentation characteristic of flavonoid compounds with 
a hydrogen at C3,167 (Fig. 3.2) established that the A ring contained two 
hydroxyls. This evidence combined with the total number of oxygens 
calculated from HRMS led to a tentative structure with two hydroxyls in 
both rings A and B. 
* Collection was carried out by Mr. Glen Wightman, Ethnobotany Project, Conservation 
Commission of the Northern Territory, Darwin. 
.. 
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Residue 
(2.8 g) 
inactive 
Dried bark 
L. cunninghamii 
water 
LC-2 
(24.3 g) 
inactive 
Extract with methanol 24 h, 
room temp, Sx. 
Evaporation. 
partitioning between water 
and EtOAc. 
filter 
VLC on Silica 
EtOAc 
LC-1 
(3.51 g) 
hexane/EtOAc 90:10 ~ 0:100 
LC-lA 
(126 mg) 
inactive 
LC-1B 
(553 mg) 
inactive 
VLC on Silica 
LC-lC 
(1.29 g) 
active 
CH2Cl2/MeOH 0:100 ~ 25:75 
LC-lCl 
(170 mg) 
inactive 
LC-1C2 
(197 mg) 
inactive 
LC-1C3 
(657 mg) 
active 
VLC on Silica 
CH2Cl2/Me0H/HC02H 90:9:1 
LC-1C3A 
(50 mg) 
inactive 
LC-1C3B 
(161 mg) 
inactive 
Scheme 3.1 
LC-1C3C 
(268 mg) 
active 
Recryst. 
LC-1C3D 
(85 mg) 
inactive 
2:1 H20/MeOH 
(3.1) 
(204 mg) 
51 
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HO 
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OH 
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Fig. 3.2 
This was supported by UV-VIS experiments,66 which showed all the 
phenolic hydroxyls to be free indicating that the sugar was attached to the 
hydroxyl at C-3. In particular, the bathochromic shifts observed on 
addition of AlCb and NaOAc/H3B03 indicated the presence of a hydroxyl 
at C-5 and ortho -3',4' substitution of the B ring in 3.1. 
The 1 H-NMR spectrum (Table 3.1) exhibited an AB system at 84.66 
and 5.18 ppm (J = 10.4 Hz) indicating that H-2 and H-3 were trans di-axial. 
·The 3' ,4' substitution pattern was confirmed by the three low field signals 
8 6.88 (J = 8.1 Hz), 6.93 (J = 1.9, 8.1 Hz) and 7.09 ppm (J = 1.9 Hz) showing 
one large ortho and one smaller meta coupling. The small coupling 
between the near identical protons at 85.97 and 5.99 ppm (J = 2.2 Hz) 
along with the UV data confirmed that the hydroxyls in ring A were in 
the 5 and 7 positions. 
From the methyl doublet at 8 1.14 (J = 6.3 Hz) it was confirmed that 
the sugar was a 6-deoxyhexose. Analysis of the couplings and comparison 
with literature data for the 6-deoxyhexoses showed, unambiguously, that 
it was the a-pyranoside of rhamnose.169 The carbon signals (Table 3.1) 
were assigned through APT (Attached Proton Test) and HETCOR (Fig. 
3.3) experiments. 
A literature search showed that all four possible diastereomers at C2 
I C3 had previously been isolated.170 The physical and spectral data, 
including optical rotation, of the 2R,3R isomer were identical to the data 
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on the compound described here, thus establishing the absolute 
stereochemistry of 3.1. 
C 8a H 8a 
2 83.3 2 5.18 (J = 10.4) 
3 77.3 3 4.66 (J = 10.4) 
4 196.0 
5 163.7 
6 96.0 6 5.97 (d, J = 2.2) 
7 165.3 
8 97.1 8 5.99 (d, J = 2.2) 
9 167.7 
10 102.4 
1' 129.0 
2' 115.4 2' 7.09 (d, J = 1.9) 
3' 146.0 
4' 146.8 
5' 120.4 5' 6.88 (d, J = 8.1) 
6' 116.0 6' 6.93 (dd, J = 1.9, 8.1) 
l" 101.3 l" 4.52 (d, J = 1.6) 
2" 71.4 2" 3.55 ( dd, J = 1.6, 3.2) 
3" 72.2 3" 3.62 (dd, J = 3.2, 9.5) 
4" 73.5 4" 3.30 (t, J = 9.5) 
5" 69.8 5" 4.58 (dq, J = 6.3, 9.5) 
6" 18.0 6" 1.14 (d, J = 6.3) 
Table 3.1 13C- and 1 H-NMR chemical shifts of compound 3.1 
a 8 in ppm from TMS in acetone-d6 and J in Hz 
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Figure 3.3 HETCOR spectrum of 3.1 
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General experimental 
Melting points were determined on a Reichert hot-stage apparatus 
and are uncorrected. Microanalyses were carried out by the Australian 
National University Microanalytical Service. 
Low resolution electron impact mass spectra (EIMS) and high 
resolution accurate mass measurements were recorded on a VG 
Micromass 7070F double-focussing mass spectrometer (low resolution EI-
MS only), or a VG ZAB-2SEQ spectrometer. The molecular ion (M+•), if 
present, significant high mass ions and the more intense low mass ions 
are reported. Chemical ionisation mass spectra (CI-MS) were obtained on 
the VG Micromass 7070F double-focussing mass spectrometer, using 
ammonia as the reagent gas. 
Infrared spectra were recorded on a Perkin-Elmer 683 or Perkin-
Elmer 1800 (FT) spectrophotometer as films (neat) or 1n 
Dichloromethane (DCM) solution. The following abbreviations were 
adopted to indicate the intensity and shape of the band: s (strong), m 
(medium), w (weak) and b (broad). 
UV-VIS spectra were recorded on a Shimadzu UV-160 or a Cary lE 
spectrometer. 
1H-NMR spectra were recorded on a Varian Gemini-300 (300 MHz), 
Varian VXR-300 (300 MHz) or a Varian VXR-500 (500 MHz). Unless 
otherwise stated the spectra were recorded at 300 MHz. Tetramethylsilane 
(TMS) was used as internal reference and the signals are quoted in o 
values (ppm downfield from TMS). The following abbreviations were 
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adopted to indicate the multiplicity and shape of the signal: s (singlet), d 
( doublet), t (triplet), q ( quartet), quin ( quintet), m (multiplet), b (broad) 
and app. (apparent). Deuterated chloroform (CDCb) was used as solvent 
unless otherwise stated. 
13C-NMR spectra were recorded on a Varian Gemini-300 (75.5 MHz) 
or a Varian VXR-300 (75.4 MHz). The solvent signal was used as internal 
reference (CDCb: 76.9 ppm, CD30D: 49.0 ppm, Acetone-d6, 206.5 ppm). 
Two dimensional NMR experiments were carried out on a Varian 
VXR-300 or a Varian VXR-500 instrument. The pulse sequences used 
were: 1H-1H-C0SY and 1H-1H-DQFC0SY (correlation between protons on 
the same, or adjacent carbons), 1H_l3C-HETCOR (one bond correlation 
between carbons and protons), 1H_l3C-LRHETCOR (multibond 
correlation between carbons and protons) and lH-lH-TOCSY (correlation 
between protons in the same spin system. 
All solvents used for extraction and chromatography were distilled 
before use. 
Chromatography, unless otherwise stated, was carried out using 
vacuum liquid chromatography (VLC) using Merck silica gel 60 
containing gypsum according to Coll & Bowden.83,84,85 Analytical thin 
layer chromatography was done on precoated aluminium Merck silica 
gel 60 PF254 plates and visualised under ultraviolet light (254 or 350 nm), 
by spraying with a 13°/o solution of vanillin in sulphuric acid or dipping 
in a 3°/o solution of phosphomolybdic acid in absolute ethanol followed 
by heating at ca. 200 °C. 
Chapter Three 57 
The microorganisms used in the antibiotic assays were Bacillus 
subtilis (gram positive), Escherischia coli (gram negative) and 
Saccharomyces carlsbergensis (yeast). The media used to cultivate the 
microorganisms were a Mueller-Hinton agar for the bacteria and 
Sabouraud' s Agar for the yeast. The plates for the assay were made up in 
batches of 10 by inocculating 100 ml of molten agar (40-45 °C) with the 
appropriate microorganism and pipetting 10 ml into sterile Petri dishes. 
The plates were stored at +4 °C and used within 5 days of preparation. 
To carry out the assay samples of extracts were dissolved in an 
appropriate solvent and aliqouts equivalent to 1 mg and 0.1 mg of the dry 
sample were used to wet 5 mm filter paper discs. The discs were air dried, 
placed on an agar plate inoculated with the microorganism and 
incubated at 28 °C overnight. The inhibition zones were measured after 
18-24 h.103 The solvent used to dissolve the extracts were included as a 
blank. 
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Experimental 
The bark was air-dried in a well ventilated room for three weeks. 
The dried material (438 g) was cut into little pieces and macerated with 
methanol (1 L) in a blender. After 24 h the extract was removed from the 
pulp by filtration and the maceration procedure repeated five times. 
The extract was concentrated at reduced pressure and partitioned 
between 200 ml water and 200 ml ethyl acetate. The mixture was filtered 
and the remaining two phases system separated. The aqueous phase was 
extracted with 50 ml ethyl acetate and the organic extracts combined. The 
ethyl acetate fraction was taken to dryness on a rotary evaporator, and 
dried at 0.5 torr for eight hours at room temperature, leaving LC-1 (3.5 g). 
The aqueous fraction was lyophilised leaving LC-2 (24.3 g). LC-1, LC-
2 and the residue from filtration was tested in the bioassay which showed 
only LC-1 to be active. LC-1 was dissolved in methanol, 5 g of Celite was 
added, and the solvent evaporated. The powder was applyed to a VLC 
column and fractionated by step-gradient elution with hexane/ ethyl 
acetate (90:10 ~ 0:100). fractions of 25 ml were collected, analysed by TLC, 
visualised by spraying with 10°/o vanillin in H2S04, and pooled into three 
fractions based on similar TLC profiles. The fractions were assayed and 
the active fraction LC-lC was further fractionated on a VLC column by 
elution with a gradient of dichloromethane/methanol (0:100 ~ 25:75). 
Three fractions were obtained and the active fraction LC-1C3 was purified 
by VLC eluted with dichloromethane/methanol/formic acid (9:90:1). Of 
the four fractions collected LC-1C3C showed significant activity. LC-1C3C 
was recrystallised from water/methanol (2:1) leaving 3.1 (204 mg, 0.05°/o). 
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(astilbin). 
White powder mp: 185-88 °C. [a] 0 : -13.7° (c = 0.035 in EtOH). 
Literature170 mp: 190-92, [a]0 : -14.6 (c = 0.52) 
59 
ranoside 
HR-EIMS: m/z 450 found: 450. 1159. Calculated for C21H22011: 450.1162, 
m/z 304 found: 304.0588. Calculated for C1sH1207 304.0583, m/z 153 
found. 153.0182. Calculated for C7H504: 153.0188. 
Negative FAB-MS (glycerol) m/z (0/o): 449 (100) (M-Ht, 303 (15) (M-H-
rhamnose)-. 
Positive FAB-MS (glycerol) m/z (0/o): 451 (27) (MH)+, 305 (32) (M+H-
rhamnose)+. 
EIMS ~/z (0/o): 450 (3), 304 (44), 275 (40), 153 (100), 123 (72). 
lH-NMR (acetone-d6, 300 MHz) o: 1.14 (d, J = 6.3, H-6"), 3.30 (t, J = 9.5, H-
4"), 3.55 (dd, J = 1.6, 3.2, H-2"), 3.62 (dd, J = 3.2, 9.5, H-3"), 4.52 (d, J = 1.6, H-
1"), 4.58 (dq, J = 6.3, 9.5, H-5"), 4.66 (d, J = 10.4, H-3), 5.18 (d, J = 10.4, H-2), 
5.97 (d, J = 2.2, H-6), 5.99 (d, J = 2.2, H-8), 6.88 (d, J = 8.1, H-5'), 6.93 (dd, J = 
1.9, 8.1, H-6'), 7.09 (d, J = 1.9, H-2'). 
13C-NMR (acetone-d6, 75.5 MHz) o: 18.0 (C-6"), 69.8 (C-5"), 71.4 (C-2"), 72.2 
(C-3"), 73.5 (C-4"), 77.3 (C-3), 83.3 (C-2), 96.0 (C-6), 97.1 (C-8), 101.3 (C-1"), 
102.4 (C-10), 115.4 (C-2'), 116.0 (C-6'), 120.4 (C-5'), 129.0 (C-1'), 146.0 (C-3'), 
146.8 (C-4'), 163.7 (C-5), 165.3 (C-7), 167.7 (C-9), 196.0 (C-4) . 
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Persoonia linearis x pinifolia 
Persoonia pinifolia, commonly known as pine-leaf geebung, is a 
bushy tree of the family Proteaceae common to the southern and eastern 
parts of Australia. In the 1940's the fruits of P. pinifolia were found to be 
active against both golden staph (Staphylococcus aureus) and typhoid 
(Salmonella typhi).153 Out of the approximately one thousand plants 
tested, only two other geebungs and two sundews were found to be active 
against both bacteria, but the active constituents were not isolated. 
Fruits of P. linearis x pinifolia 
Bioassay guided fractionation of extracts of the fruit fromjr. linearis x 
pinifolia resulted in the isolation of one active compound, which 
showed intense broad spectrum activity against B. subtilis, E. coli and 
Phytophthera cinnamomii. 
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This proved to be a new natural product whose structure 3.2 was 
elucidated by MS and NMR spectroscopy and confirmed by X-ray 
crystallography. 
OH 0 
HO 
Isolation and structure elucidation 
Inquiries at the National Botanic Gardens in Canberra showed that 
of the four specimens of P. pinifolia originally in their collection, only 
one small bush was left. Apparently P. pinifolia cross hybridises readily 
with closely related species and two large specimens of the hybrid 
P. linearis x pinifolia were growing in the Botanic Gardens. It was 
therefore decided to continue work on the fruits from these and 
permission to harvest fruit from the two trees was obtained from the 
National Botanic Garden management. The green fruits (see photograph 
p. 61) were picked in late September when abundant. The fruits were 
lyophilised, macerated and extracted with solvents of increasing polarity 
and the extracts fractionated and purified according to Scheme 3.2. 
Ions at m I z 385 (M-H)-and 387 (M+H)+ in the negative and 
positive FAB-MS spectra respectively suggested that the molecular mass 
of 3.2 was 386 and from FAB-MS data and elemental analysis a molecular 
formula of C17H22010 could be calculated. 
-. 
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Persoonia linearis x pinifolia 
fruits 
heptane 
PL-1 
(3.19 g) 
PL-2 
(782 mg) 
(220 g) 
I 
VLC on silica 
CH2Cl2/MeOH 95:5 ~ 0:100 
PL-3D 
(461 mg) 
VLC on silica 
CH2Cl2/MeOH 95:5 ~ 0:100 
PL-3Dl 
(250 mg) 
EtOAc 
PL-3 
(2.13 g) 
active 
MeOH 
PL-4 
(20.3 g) 
active 
Ether precipitation 
PL-4A 
(10.2 g) 
active 
Precipitate 
(10.1 g) 
VLC on silica 
CH2Cl2/MeOH 95:5 ~ 0:100 
PL-4A3 
(2.0 g) 
VLC on silica 
CH2Cl2/MeOH 90:10 ~ 50:50 
PL-4A3B 
(1.58 g) 
VLC on silica 
EtOAc/MeOH 90:10 ~ 70:30 
PL-4A3B2 
(0.93 g) 
Recrystallisation 
MeOH/ diisopropylether 
3.2 
(1.1 g) 
Scheme. 3.2 
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Signals at 8 3.0 -5.0 ppm in the proton spectrum and 65-105 in the 
13C spectrum (Table 3.2) suggested that 3.2 was a glycoside, which was 
corroborated by the signal at 8 4.74 ppm showing the characteristic 
doublet for an anomeric proton U = 8.0 Hz). Two one proton signals at 
8 6.03 and 6.38 ppm U = <3 Hz) indicated the presence of an exocyclic 
methylene group. Two doublets at 8 6.70 and 6.94 ppm (J = 8.9 Hz) 
integrating for four protons were indicative of a para substituted 
aromatic system possessing electron donating groups. 
The double bond equivalents were calculated to be 7 from the 
molecular formula, and the seven degrees of unsaturation could all be 
accounted for by the aromatic ring (4), a cyclic hexose (1) and an a-P 
unsaturated ester (2), the latter indicated by the signal at 8 167.5 ppm in 
the carbon spectrum. 
In the COSY spectrum two isolated proton spin systems could be 
identified in the region containing hydroxyl substituted resonances. The 
first was a seven proton system (5 methine protons and a methylene 
group) supporting the presence of a hexose sugar and the other a three 
proton ABX system, of which the X proton at 8 4.61 ppm also showed a 
coupling to the two exocyclic methylene protons, indicating that it was 
part of the ester moiety. This together with the two signals at 8 65.4 and 
66.9 ppm, in the APT spectrum, corresponding to two oxygenated 
methylene carbons, led to the three fragments in Fig. 3.4 which had to be 
pieced together to the full structure of 3.2. 
The number of oxygenated aliphatic carbons in the carbon spectrum 
(8) (Table 3.2) led to the remaining two oxygens being the para 
substituents of the aromatic system supported by the two quarternary 
signals at 8 152.4 and 154.1 ppm in the 13C spectrum. 
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C 8a H 8b 
1 103.7 1 4.81 ( d, J = 8.0 Hz) 
2 75.1 2 3.47 (dd, J = 8.0, 9.0 Hz) 
3 78.0 3 3.57 (t, J = 9.0 Hz) 
4 72.0 4 3.49 (dd, J = 9.0, 10.0 Hz) 
5 75.5 5 3.75 (ddd, J = 2.5, 7.0, 10.0 Hz) 
6 65.4 6a 4.28 (dd, J = 7.0, 12.0 Hz) 
6b 4.55 (dd, J = 2.5, 12.0 Hz) 
1' 167.5 
2' 142.3 3' 4.61 (ddt, J = 1.5, 4.0, 6.5 Hz) 
3' 72.3 4'a 3.43 (dd, J = 7.0, 11.5 Hz) 
4' 66.9 4'b 3.72 (dd, J = 4.0, 11.5 Hz) 
5' 127.2 5'a 6.03 (d, J = 1.5 Hz) 
5'b 6.38 (d, J = 1.5 Hz) 
1" 152.4 
2",6" 116.9 2",6" 6.69 (d, J = 8.9 Hz) 
3",5" 119.8 3",5" 6.93 (d, J = 8.9 Hz) 
4" 154.1 
Table 3.2. 
a 13C-signals were assigned from a HETCOR experiment 
b Coupling constants obtained from a resolution enhanced spectrum 
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OH 0 6 
S" OH 
S' 
Fig. 3.4 
The fact that the signals for the two protons in the 6 position of the 
sugar(<> 4.28 and 4.54 ppm) were shifted downfield by -1.1 ppm compared 
to similar shifts in free hexosesl 71 suggested that the ester moiety was 
attached to the C6 position of the sugar. This, however, could not be 
confirmed from long range HETCOR experiments. A series of spectra 
were run, optimised for different long range coupling constants, but no 
crosspeaks were observed between the ester carbonyl and either of the 
protons attached to C6 of the sugar. The intense cross peak between the 
anomeric proton and the two aromatic carbons at<> 116.9 ppm in the long 
range HETCOR spectrum, however, proved that the hydroquinone was 
attached to the sugar through the glycosidic linkage, thus confirming that 
the ester substituent was attached to the 6-position. 
Since all the vicinal couplings in the sugar, from the anomeric to 
the proton at CS, were large(> 7 Hz) this indicated that all substituents on 
the pyranose were equatorial. Only glucose, as the ~-glycoside, has an all 
equatorial configuration and comparison with known 6-0-acylated 
hydroquinone glycosides172 supported this conclusion. From a 
biosynthetic viewpoint it was not unreasonable to assume that the sugar 
was present as the D-form. 
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The absolute stereochemistry at C3' in the a-~ unsaturated ester was 
determined by acidic hydrolysis of 3.2. TLC showed the formation of 
three compounds, which were separated by column chromatography. 
Hydroquinone was identified by comparison with an authentic 
sample and the acid side chain isolated as the lactone 3.3. 
(OYO 
HO/-"\ 
3.3 
The 1 H and 13C NMR data for 3.3 were identical to those reported 
for the previously isolated and synthesised (-)-(S)-3-hydroxy-2-
methylene-y-butyrolactone ((-)-tulipalin B).173,174 The lactone 3.3 formed 
on hydrolysis of 3.2 showed a positive optical rotation, that is, opposite to 
that of the previously described lactone173 establishing that the absolute 
stereochemistry of the sidechain in 3.2 was (R). 
The structure of 3.2 was verified by X-ray crystallography* (Fig 3.5) 
confirming that the sugar was D-glucose based on the absolute 
configuration at C3' being (R). 
Suitable crystals were grown by slow evaporation of a solution of 3.2 
in methanol/ ethyl acetate. A complete summary of the data collection, 
structure refinement and atom coordinates is given in Appendix A. 
* The author gratefully acknowledges Dr. A. C. Willis for the X-ray diffraction analysis . 
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OH 0 
HO 
OH 
0110 
0109 
Cl 15 
0103 
0104 
Fig 3.5 ORTEP diagram of 3.2 
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a-Methylene acid derivatives have long been known for their 
biological activities such as allergenic,175 antibiotic176 and antitumour 
activity.177 
Five compounds containing an a-methylene-y-butyric acid moiety 
have been described.178,179 These are 1-tuliposide A (3.3) and B (3.4), 6-
tuliposide A (3.5) and B (3.6) and tuliposide D (3.7). 
0 R 
OH 
3.5 R = H 
3.6 R = OH 
OH 
OH 
0 
OH 
0 
3.3 R = H 
3.4 R = OH 
OH 
R 
0 
OH 
0 
3.7 
OH 
OH 
Compounds 3.3 and 3.4 are found in most species of Alstroemeria 
(Alstroemeriaceae) and Tulipa (Liliaceae) and are responsible for the 
contact dermatitis, known as "tulip fingers", commonly found in people 
working with plants from these families.180 They have also been found 
to possess antibacterial and antifungal activity.178,179 
Although 3.3 and 3.4 showed antibiotic activity against B. subtilis, 
the activity disappeared over time. Even at - 20 °C the 1-acyl glycosides 
were not stable, undergoing acyl migration to the more stable 6-0-
isomers 3.5 and 3.6, which proved to be inactive.173 It seems likely that 
the reason for the activity of 3.3 and 3.4 is caused by hydrolysis of the 
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labile glycosidic ester bond. The a-methylene-y-butyric acid derivatives 
released, either as the lactone or the free acid, are probably the 
compounds responsible for the actual activity. In fact both the free acid 
and the lactone have been shown to possess antibacterial activity.173 The 
6-0-acyl isomers are less prone to hydrolysis because of the more stable 
ester bond and this might be the reason why they do not show any 
activity. 
It is interesting to note, however, that the compound 3.2 described 
in this chapter, although similar to the inactive compounds 3.5 and 3.6, 
shows potent antibacterial and antifungal activity. Based on this 
observation it seems likely that the hydroquinone moiety is essential for 
the antibiotic activity of 3.2. 
Experimental 
The fruits of P. linearis x pinifolia (930 g) were picked at the 
Australian National Botanic Gardens, Canberra. The fruits were 
lyophilised and the dried material (220 g) macerated with heptane (1 L). 
The pulp was left for 24 h, filtered and the maceration procedure repeated 
4 times. The pulp was then extracted vvith dichloromethane, ethyl acetate 
and methanol consecutively (5x 1 L, 24 h). The extracts were concentrated 
in vacuo leaving PL-1 (3.2 g), PL-2 (0.78 g), PL-3 (2.1 g), and PL-4 (20.3 g). 
The four extracts were tested and PL-3 and PL-4 were found to be active 
against B. subtilis, E. coli, and P. cinnamomii. 
PL-3 was fractionated by VLC on silica step-gradient eluted with 
dichloromethane/methanol (95:5 ~ 0:100). The fractions were analysed 
by TLC and visualised by dipping in a 5°/o solution of phosphomolybdic 
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acid in ethanol followed by heating. Five fractions were obtained and 
the active fraction PL-30 further purified by VLC eluted with 
dichloromethane/methanol (90:10 ~ 60:40). PL-301 was recrystallised 
from methanol/ diisopropylether to give 3.2 (210 mg). 
PL-4 was dissolved in methanol (50 ml) and poured into 
diethyjether (500 ml), with rapid stirring, and the suspension filtered 
leaving 10.1 g of precipitated material. The filtrate was concentrated 
leaving PL-4A (10.2 g). The activity was concentrated in PL-4A which was 
fractionated by VLC on silica eluted with dichloromethane/methanol 
(90:10 ~ 0:100). Of the four fractions obtained the active PL-4A3 was 
further fractionated by VLC eluted with dichloromethane/methanol 
(90:10 ~ 50:50). The active fraction was further purified by VLC using a 
different solvent system ethyl acetate/methanol (90:10 ~ 70:30). 
The active fraction PL-4A3B2 was recrystallised from methanol 
/ diisopropylether to give 3.2 (930 mg). 
Total yield of 3.2 (1.1 g, 0.55°/o). 
Colorless crystals from ethanol/ diisopropylether mp: 165-67 °C. 
[a]220 : - 60.3 °, c = 0.025 in methanol. 
Microanalysis found. C: 52.37, H: 5.63. Cale. for C17H22010. C: 52.85, H: 5.74 
FAB-MS (negative, glycerol) m/z (0/o): 385 (56) (M-H)-, 355 (46), 271 (100) 
(M-acid sidechain)-. 
FAB-MS (positive, glycerol) m/z (0/o): 387 (37) (M+H)+ 
1H-NMR (acetone-d6, 500 MHz) 8: 3.44 (lH, dd, J = 7.0, 11.5 Hz, H4'a), 3.47 
(lH, dd, J = 8.0, 9.0 Hz, H2), 3.49 (lH, dd, J = 9.0, 10.0 Hz, H4), 3.57 (lH, t, J = 
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9.0 Hz, H3), 3.72 (lH, dd, J = 4.0, 11.5 Hz, H4'a), 3.75 (lH, dd, J = 2.5, 7.0, 
10.0 Hz, HS), 3.70 (dd, J = 3.1, 11.5 Hz, H4'b), 4.28 (dd, J = 7.0, 12.0 Hz, H6a), 
4.55 (dd, J = 2.5, 12.0 Hz, H6b), 4.61 (ddt, J = 1.5, 4.0, 6.5 Hz, H3'), 
4.81 (d, J = 8.0 Hz, Hl), 6.03 (d, J = 1.5 Hz, HS'a), 6.38 (d, J = 1.5 Hz, HS'b), 
6.69 (2H, d, J = 8.9 Hz, H3", HS"), 6.93 (2H, d, J = 8.9 Hz, H2", H6"). 
13C-NMR (CD30D, 75.5 MHz) o: 65.4 (C6), 66.9 (C4'), 72.0 (C4), 72.3 (C3'), 
75.1 (C2), 75.5 (CS), 78.0 (C3), 103.7 (Cl), 116.9 (C2", C6"), 119.8 (C3", CS"), 
127.2 (CS'), 142.3 (C2'), 152.4 (Cl"), 154.1 (C4"), 167.5 (Cl'). 
( + )-(R)-3-Hydroxy-2-methylene-:y-butyrolactone, ( + )-tulipalin B, (3.3) 
Colorless oil [a]200 : + 85.5 °, c = 0.051 in CDCb. (Lit.174: - 82 ° (S-form)). 
HR-EIMS: m/z 115 found 115.0397. C5H7C)3 requires 115.0395. 
EIMS m/z (0/o): 115 (40) (M+H)+, 84 (100) [M-CH20]+, 56 (94) [84-CO]+. 
1H-NMR (CDCl3, 300 MHz) o: 4.20 (dd, J = 3.6, 10.1 Hz, H4a), 4.52 (dd, J = 
6.6, 10.1 Hz, H4b), 4.91 (bm, H3), 6.00 (d, J = 2.0 Hz, HSa), 6.33 (d, J = 2.0 Hz, 
HSb). 
13C-NMR (CDCl3, 75.5 MHz) o: 67.1 (C3), 73.6 (C4), 126.9 (CS), 137.4 (C2), 
170.1 (Cl). 
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Pterocaulon serrulatum 
Pterocaulon serrulatum is a herbacious plant of the family 
Asteraceae commonly known as "fruit salad plant" by Australian 
aborigines because of its sweet aromatic fragrance. It is common from 
Western Australia to Queensland and is usually found near rocky 
drainage lines or seasonal creeks. In habitated areas it is considered a 
weed and it is commonly found wherever the ground is disturbed, such 
as construction sites. It is one of the few plants aborigines collect and dry 
for later use, when fresh leaves are not available.154 
A handful of leaves and twigs are boiled in half a billycanful of water, 
and the liquid strained. This liquid is used as a wash to treat skin 
disorders such as scabies, ringworm and sores and cuts.154 It has also been 
"to be. 
reported iused as a remedy for respiratory problems.152 No previous 
studies of the chemical constituents of P. serrulatum have been reported. 
Pterocaulon serrulatum 
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In the present study three active compounds were isolated from 
P. serrulatum in addition to three inactive coumarins 3.8, 3.9 and 3.10. 
OMe 
MeO 
0 0 MeO 0 
OMe 
3.8 3.9 3.10 
The active compounds were the flavanone 3 .11 and two 
sesquiterpenes 3.12 and 3.13. 
HO 
OH 
OH 
3.12 
. .. Jg 
0 
3.11 
/""'" 
HO 
3.13 
Isolation and Structure elucidation 
The aerial parts of P. serrulatum were collected in the Nitmiluk 
National Park, Katherine N. T. and a voucher specimen (G. M. 
Wightman 6122) deposited at the Northern Territory Herbarium, 
Darwin.* The dried material was extracted and the extracts purified by 
bioassay guided fractionation according to Scheme 3.3 and Scheme 3.4. 
* Collection was carried out by Mr. Glen Wightman, Ethnobotany Project, Conservation 
Commission of the Northern Territory, Darwin. 
• 
-
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Pterocaulon serrulatum 
heptane 
PS-1 
(7.3 g) 
active 
PS-2 
(18.8 g) 
Suspension in ether 
Filtration 
PS-1B 
(6.2 g) 
Extraction 
EtOAc 
PS-3 
(3.2 g) 
Precipitate (inactive) 
PS-lA 
(1.1 g) 
MeOH 
PS-4 
(2.8 g) 
Flash column (silica) 
hexane/CHzClz/EtOAc 2:1:1 
recrystallisation 
3.8 3.9 3.10 
(16 JJlg) (76 mg) ( 430 mg) 
VLC on silica. Hexane/EtOAc 100:0 ~ 0:100 
PS-1Bl 
(530 mg) 
I 
active 
I 
PS-1B2 
(2.1 g) 
VLC 
PS-1B2B 
I 
I 
active 
I 
PS-1B3 
(837 mg) 
VLC 
PS-1B3B 
I 
active 
I 
PS-1B4 
(602 mg) 
VLC 
PS-1B4A 
I 
VLC on silica 
hexane/EtOAc 9:1 
3.12 
(168 mg) 
PS-1BS 
(2.0 g) 
Scheme 3.3 Extraction and purification of P. serrulatum. 
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I 
PS-2A 
(138 mg) 
I 
I 
PS-2B 
(2.0 g) 
PS-2C1A 
(496 mg) 
active 
VLC on silica 
PS-2 (9 g) 
VLC on silica 
CH2Cl2/EtOAc 100:0 -t 0:100 
PS-2C 
(2.6 g) 
active 
I 
PS-2D 
(2.4 g) 
Suspension in ether 
Filtration 
PS-2Cl 
(2.1 g) 
active 
VLC on silica 
1 
precipitate 
PS-2C2 
(583 mg) 
THF /hexane 10:90 -t 100:0 
I 
PS-2C1B 
(1.0 g) 
CH2Cl2/MeOH 100:0 -t 0:100 
PS-2C1Al 
(43 mg) 
I 
PS-2C1A2A 
active 
VLC on silica 
Et0Ac/CH2CI2 
99:1 -t 95:5 
3.11 
(66 mg) 
I 
PS-2C1A2 
(378 mg) 
VLC on silica 
EtOAc/hexane 20:80 -t 100:0 
I 
PS-2C1A2C 
active 
silica flash chrom. 
EtOAc/CH2CI2 
10:90 
3.13 
(20 mg) 
Scheme 3.4 Purification of PS-2. 
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The mixture of coumanns 3.8, 3.9 and 3.10 which was left after 
washing the heptane extract (PS-1) with ether was separated by flash 
column chromatography and recrystallisation. From the AB system (J = 
9.3 - 9.6 Hz), for the protons at C3 and C4, in the lH-NMR spectra it was 
clear that all three coumarins were devoid of substituents at C3 and C4. 
0 
< 0 7 
8 
3.8 
The position of the methylenedioxy moiety in 3.8 was 
unambiguously determined because of the absence of any ortho-coupled 
aromatic protons in the lH-NMR spectrum. Comparison of melting 
point and lH- and 13C-NMR data with previously published data 
· confirmed the structure to be that of the known coumarin, ayapin.182 
OMe 
0 
3.9 
The structure of 3.9 was determined by comparison of melting point 
and NMR data with literature values. The data obtained for 3.9 was 
identical with that published for cabreuva lactone.183 
MeO 
Meo 
OMe 
3.10 
0 
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Compound 3.10 was identified as the 6,7,8-trimethoxy isomer by its 
melting point (104-6 °C).184 The melting points of the other isomers were 
quite different (5,6,7: 74-75 °C and 5,7,8: 179-80 °C).185 The 5,6,8 
substitution pattern has not been reported. 
(+)-(2S)-5,7-jihydroxyflavanone (pinocembrin) (3.11) 
The EIMS spectrum of 3.11 showed a strong molecular ion at m / z 
256. From the HR-MS measurement of this ion and microanalysis its 
molecular formula C1sH 1204 was calculated. The ion at m I z 179 
indicated a loss of a C6Hs fragment and the ion at 153 the presence of a 
trihydroxylated aromatic ketone unit.168 This was supported by the two 
ions at m I z 104 and 152 corresponding to to a retro Diels Alder 
fragmentation168 (Fig. 3.6). The MS information indicated that 3.11 was a 
flavonoid with two hydroxyls in the A ring and no substitution in the B 
ring]his was corroborated by the ketone signal at 8 195.5 ppm in the 13C-
NMR spectrum. 
m/z 179 
+ 
HO 0 • 
HO 
-. 
c~ 
m/z 104 0 OH 
0 
Fig. 3.6 Major fragmentations of 3.11. 
Two one proton doublets at 8 5.99 and 6.01 ppm (J = 1.9 Hz) in the 
1H-NMR spectrum was an indication of two protons meta to each other 
and a five proton multiplet centered at 8 7.42 ppm supported the 
presence of an unsubstituted phenyl fragment. 
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The ABX system at 8 2.78, 3.08 and 5.40 ppm for the C ring protons 
proved 3.11 to be a flavanone derivative. The chemical shift of the X 
proton (5.40 ppm) ruled out an iso-flavanone structure. This was 
supported by shift values calculated for both flavanone and zso-
flavanone using Schoolery' s rules.186 Calculated shifts for a flavanone. A, 
B = 2.07 ppm, X = 5.31 ppm. The calculated shift for an iso-flavanone was 
better described as a AB2 system. A = 3.46 ppm, B = 3.96 ppm. 
Biosynthetic considerations combined with the meta relationship 
between the two A ring protons suggested they were attached to the 5 and 
7 positions. 
The spectral data and optical rotation for 3.11 were found to be 
identical to literature values for pinocembrin 187,188 which established the 
absolute stereochemistry as (2S). 
14-Hydroxy-~-caryophyllene (3.12) 
The EIMS spectrum showed a weak molecular ion at m/z 220 which 
by accurate mass measurement corresponded to a molecular formula of 
C1sH240 suggesting that 3.12 was a mono-oxygenated sesquiterpene. 
Both the lH and 13C NMR spectra, however, contained too many signals 
for a molecular weight of 220. The fact that the 13C spectrum contained 30 
signals seemed to indicate that although the sample was homogenous by 
TLC it could be a mixture of isomers. Since the 1 H spectrum showed 
signals for protons on double bonds, an attempt was made to separate the 
mixture by column chromatography on silver nitrate impregnated silica. 
No separation was accomplished and subsequent analysis by HPLC and 
GC-MS confirmed that the sample was homogenous and more than 99°/o 
pure. Having established that the sample consisted of only one 
compound the only explanation for the doubling up of the signals in the 
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NMR spectra was that the compound was a mixture of two conformers, 
which were not interconverting on the NMR timescale. 
The two sets of one proton singlets between b 4.8 and 5.1 ppm 
indicating an exocyclic methylene group. This fact combined with the 
indication of a gem-dimethyl cyclobutane fragment from the EIMS 
spectrum (m/z 56 [C4Hs]+ and 164 [M-C4Hs]+) pointed to the compound 
being a caryophyllene derivative. A literature search revealed a 
compound with identical optical rotation and spectral data which had 
been shown to be a mixture of conformers by variable temperature 1 H-
NMR experiments.189 This compound was claimed to be the 9-epimer of 
14-hydroxy-~-caryophyllene 3.12a189,190 based on the fact that it was 
different from the product obtained by allylic oxidation of 
~-caryophyllene 3.14, and from nOe experiments. 
12 2 3 
13 ....... l 
11 OH 
14 
10 6 
7 
15 
3.12a 
During the time that the present study was being carried out the 
structure was reassigned to that of 14-hydroxy-~-caryophyllene 3.12 and 
not the epimer.191,192 
OH 
3.12 
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Because of the reversibility of the addition of selenium dioxide to 
the allylic bond the product obtained by oxidation of ~-caryophyllene, is 
the more stable iso-caryophyllene alcohol 3.15. (Fig. 3.7) 
3.14 \ / 
II• I. OH I 
Se 
•• 
0 
OH 
3.15 
Scheme 3.7 Se02 oxidation of ~-caryophyllene. 
4,s-f poxy-13-hydroxy-P-caryophyllene (3.13) 
The 15 signals present in the 13C spectrum of 3.13 and accurate mass 
measurement of the high mass ions in the EIMS spectrum indicated that 
3.13 was also a sesquiterpene. 
The CIMS spectrum of 3.13 showed an ion at m I z 237 which 
suggested a molecular weight of 236. This was supported by ions in the 
EIMS spectrum which, although it did not show a molecular 10n, 
-• i 
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contained ions at m I z 221 and 205 indicating losses of a methyl and a 
hydroxymethyl group respectively. There are, however, no even mass 
fragment ions present corresponding to a retro 2+2 cleavage of a 
cyclobutane ring. The composition of the fragments at m I z 221 and 205 
were calculated from HR-EIMS experiments to correspond to C14H2102 
and C14H210. Adding a methyl and a hydroxymethyl group to these 
respectively, gave the composition of the molecular species as C1sH2402. 
The 1 H-NMR spectrum of 3.13 showed similarities to that of 3.12 
indicating it could be closely related. Two methyl singlets were present at 
8 1.06 and 1.20 ppm, while an AB system at 8 3.52 and 3.68 ppm indicated 
a hydroxymethyl group on a quarternary carbon and two one proton 
singlets at 8 4.90 and 5.02 ppm corresponding to an exocyclic methylene 
group. 
The caryophy llene skeleton was confirmed from a DQF-COSY 
experiment (Fig. 3.8) showing two isolated spin systems, an eight proton 
system (H's 10, 9, 1, 2 and 3) and a five proton system (H's 5, 6, 7). 
The lack of a vinylic proton and the extra oxygen in the molecular 
formula led to the assignment of a tentative structure A for 3.12 namely 
the ~-epoxide of 3.12 or its 9-epi isomer. The former was subsequently 
ruled out, however, since a compound with this structure has been 
described. 
12 2 _3 
1/ 0~ 4 14 
13 ...... . ..... 1-1---'- H -~ OH 
-~' --v--- H 5 
10 9 6 
8 7 
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A 
Chapter Three 
F2 
(ppm) 
1.2 
1.4 
1.6 
1.8 
2.0 
2.2 
2.4 
2.6 
2.8 
3.0 
5 
3.0 2.8 
~ 
c:c 
~ 
9 
2.6 2.4 
-9 
L~~ 
2b 
~ 
-
3b" 
7b 
2.2 2.0 1.8 
F1 (ppm) 
/111111•• 
HO 
H 
H 
;; 
-
1.6 
H H 
3a 
2a 6a 
• L 
'<:l."'C 
~~ 
-~ 
"Q'Q 
~:. 
1.4 1.2 1.0 0.8 
Fig. 3.8 High field section of the DQF-COSY spectrum of 3.13 
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The 9-epi structure for A was supported by the separation of the 
chemical shifts of the methyl groups (~8 ,... 0.2 ppm), a feature which had 
been reported for other 9-epi-caryophyllenes.191,193 It seemed unusual, 
however, that both the caryophyllene 3.12 and an 9-epi-caryophyllene 
would co-occur. 
To probe the relative stereochemistry at C 1, C9, C4 and Cs a NOESY 
experiment was performed, and although most of the nOe interactions 
could be explained by the 9-epi structure some crucial interactions were 
either missing or could not be adequately explained on the basis of a cis-
ring junction. Consideration was then given to the possibility that 3.9 
was based on an iso-caryophyllene skeleton. 
The epoxides of 14-hydroxy-iso-caryophyllene 3.16 and 3.17 were 
prepared by selenium dioxide oxidation of ~-caryophyllene 3.14 and 
subsequent epoxidation with m-chloroperbenzoic acid. 
OH OH 
3.16 3.17 
The spectral data for 3.13 were compared with the data for 3.16 and 
3.17 and the epoxides of 14-hydroxy-~-caryophyllene 3.18 and 3.19 
previously synthesised from the natural product.192 (Fig. 3.9). 
OH OH 
3.18 3.19 
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Comparison of the 1 H-NMR spectra in Fig. 3.9* clearly showed that 
3.13 was different from the four epoxides derived from either of the 
14-hydroxy-caryophyllenes. Since all three methyl groups in P-
caryophyllene itself are on quarternary carbons a revised structure was 
proposed with the hydroxyl on either C12 or C13. 
12-Hydroxy-4,5-epoxy-P-caryophyllene 3.20 has been reported194,195 
but although the spectral data for 3.13 and 3.20 showed similarities the 
fact that 3.20 was a solid,194 whereas 3.13 was an oil, suggested that the 
two compounds were different. In addition the NOESY data for 3.13 was 
not consistent with the structure of 3.20 because of the interaction 
observed between Hl and the 12 methyl group. 
HO 
3.20 
The only structure remaining was the 13-hydroxy isomer and by 
comparison with a Dreiding model, all NOESY interactions could be 
explained satisfactorily as shown in Fig. 3.10. The important interactions 
derived from the interpretation of the NOESY spectrum were Hl ~ 
12Me ~ HlOP ~ HlOa ~ H9, confirming the trans relationship between 
Hl and H9 and the hydroxyl attached to C13. The protons on C13 showed 
interactions with H2a confirming that it was on the a face of the 
molecule. The interaction between HS and Hl, H3P and H6P in turn 
established that the epoxide was on the topface of the molecule. 
* The author gratefully acknowledges Prof. A. Barrero for supplying the original 1 H- and 
13C-NMR spectra of 3.18 and 3.19 in Fig. 3.9. 
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The ~-orientation of the epoxide was corroborated by an interaction 
between 14Me and H2a. 
An attempt to make a crystalline derivative of 3.13 was unsuccesful. 
Because the p-bromobenzoate of 3.16 was not crystalline189 the 4-bromo-
3,5-dinitrobenzoate 3.21 of the alcohol 3.13 was prepared, but this also was 
not crystalline. The NOESY spectrum of the benzoate showed the same 
interactions as 3.13 as well as an interaction between the aromatic 
protons and Hl and the 12Me. 
Since all ~-caryophyllene derivatives with confirmed absolute 
configuration so far isolated from plants have shown the (1R,9S) 
configuration it can be assumed that 3.13 possesses the same absolute 
s tereochemis try. 
0 
/""'" 
0 
3.21 
/""'" 
HO 
3.13 
There are few references to the biological activity of caryophyllenes 
but ~-caryophyllene itself has been shown to possess antibiotic196 and 
antiacne197 activity and a few derivatives of caryophyllene have shown 
antibiotic activity.198 
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Experimental 
The dried plant material (273 g) was macerated with heptane (1 L) 
and the pulp left extracting overnight. Extraction wit+eptane was 
repeated 3x and the solvent evaporated in vacuo leaving PS-1 (7.3 g) as a 
semicrystalline mass. Subsequent extractions with dichloromethane, 
ethyl acetate and methanol ( 4x 1 L, 24 h) respectively yielded PS-2 
(18.77 g), PS-3 (3.19 g) and PS-4 (2.3 g). 
PS-1 was suspended in ether and filtered leaving PS-lA (1.1 g) and 
the filtrate PS-1B (6.2 g). PS-lA which contained three major compounds 
showing strong fluorescence on TLC (350 nm) was purified by flash 
chromatography (silica) eluted with hexane/ dichloromethane/ ethyl 
acetate (50:25:25) leaving 3.8 (16 mg), 3.9 (76 mg) and 3.10 (430 mg) after 
recrystallisation from ethanol. 
PS-1B was fractionated by VLC on silica gradient eluted with 
hexane/ ethyl acetate (100:0 ~ 0:100) giving five fractions of which 
PS-1B2, PS-1B3 and PS-1B4 were active in the bioassay. PS-1B3 was 
fractionated by VLC on silica eluted with dichloromethane which 
removed most of the fluorescent material in fraction PS-1B3A. The 
active fraction PS-1B3B was pooled with PS-1B2 and PS-1B4 based on the 
similarity in their TLC traces. The combined fractions were purified by 
VLC on silica eluted with hexane/ dichloromethane/ ether (70:20:10 ~ 
0:60:40) leaving 3.7 (172 mg). Further purification by flash column 
chromatography on silica impregnated with 5 °/o silver nitrate removed 
the last traces of fluorescent material leaving pure 3.12 (165 mg, 0.06 °/o). 
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PS-2 was fractionated by VLC on silica gradient eluted with 
dichloromethane/ ethyl acetate (100:0 ~ 0:100) giving four fractions based 
on TLC similarities. Bioassays showed PS-2C (2.6 g) to be the active 
fraction and this was further purified by suspension in ether followed by 
filtration. The activity was retained in the filtrate PS-2Cl which after 
concentration was purified by VLC on silica gradient eluted with 
hexane/THF (90:10 ~ 0:100). The active fraction PS-2C1A was further 
purified by VLC on silica eluted with pure dichloromethane to remove 
most of the fluorescent material and subsequently with 
dichloromethane/methanol (100:0 ~ 95:5). A final purification by flash 
column chromatography on silica eluted with dichloromethane/ethyl 
acetate (90:10) gave pure 3.13 (41 mg, 0.02 °/o). 
VLC of PS-2C1A2A on silica eluted with dichloromethane/ ethyl 
acetate (99:1 ~ 95:5) gave pure 3.11 (66 mg, 0.03 °/o). 
6,7-Methylenedioxycoumarin (ayapin) (3.8) 
Colorless needles mp: 217-20 °C. (Lit182: 224 °C). 
EIMS m/z (0/o): 190 (100), [M]+, 162 (39) [M--CO]+, 132 (19) [162--CH20]+. 
1H-NMR (CDCl3, 300 MHz) o: 6.09 (2H, s, O-CH2-0), 6.29 (lH, d, J = 9.5 Hz, 
H3), 6.82 (lH, s, HS), 6.84 (lH, s, HS), 7.59 (lH, d, J = 9.5 Hz, H4). 
13C-NMR (CDCl3, 75.5 MHz) o: 98.4 (CS), 102.4 (O-CH2-0), 105.0 (CS), 
112.6 (ClO), 113.3 (C3), 143.5 (C4), 144.9 (C6), 151.2 (C7), 151.3 (C9), 161.2 (C2) 
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Colorless needles mp: 200-2 °C. (Lit183: 200-2 °C). 
EIMS m/z (0/o): 220 (100) [M]+, 205 (5) [M-Me]+, 192 (62) [M-CO]+, 177 (43) 
[205--CO]+, 147 (39) [177-CH20]+. 
lH-NMR (CDCl3, 300 MHz) 8: 4.13 (3H, s, OMe), 6.02 (2H, s, O-CH2-0), 6.20 
(lH, d, J = 9.6 Hz, H3), 6.51 (lH, s, H8), 7.93 (lH, d, J = 9.6 Hz, H4). 
13C-NMR (CDCl3, 75.5 MHz) 8: 92.3 (C8), 101.8 (O-CH2-0), 106.5 (ClO), 
111.6 (C3), 131.7 (C6), 138.0 (CS), 138.9 (C4), 151.5 (C7), 152.6 (C9), 161.4 (C2). 
6.7.8-Trimethoxycoumarin (dimethylfraxetin) (3.10) 
Colorless needles mp: 104-6 °C. (Lit184: 103-5 °C). 
EIMS m/z (0/o): 236 (100) [M]+, 221 (34) [M-Me]+, 193 (22) [221-CO]+, 178 
(11) [193-Me]+, 150 (28) [178-CO]+. 
1H-NMR (CDCl3, 300 MHz) 8: 3.92 (3H, s, C8-0Me), 4.00 (3H, s, C6-0Me), 
4.04 (3H, s, C7-0Me), 6.35 (lH, d, J = 9.5 Hz, H3), 6.72 (lH, s, HS), 7.66 (lH, 
d, J = 9.5 Hz, H4). 
13C-NMR (CDCl3, 75.5 MHz) 8: 56.1 (C7-0Me), 61.3 (C6-0Me), 61.6 (C8-
0Me), 103.6 (CS), 114.2 (ClO), 114.9 (C3), 140.9 (C9), 142.8 (C7), 143.4 (C4), 
145.7 (C6), 149.9 (C8), 160.3 (C2). 
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l) 
3S)-5,7-~ihydroxyflavanone (pinocembrin) (3.11) 
Colorless needles mp: 200-2 °C. (Lit.187: 192-93 °C ). 
[a]o: + 47.4 °, c = 0.032 in acetone (Lit.187 + 45.3 °, c = 0.9 in acetone). 
Microanalysis found. C: 70.39, H: 4.71. Cale. for C1sH1204. C: 70.31, H: 4.72 
HR-EIMS: m/z 256. Found 256.0718. Cale. for C1sH1204: 256.0736 
EIMS m/z (0/o): 256 (59) [M]+, 179 (79) [M-C6Hs]+, 153 (27) [PhCO]+, 152 
(100) [M-styrene], 124 (58) [152-CO]+, 104 (38) [PhCO]+, 77 (42) [C6Hs]+. 
lH-NMR (CDCl3, 300 MHz) 8: 2.78 (lH, dd, J = 3.1, 17.1 Hz, H3a), 3.08 (lH, 
dd, J = 13.0, 17.1 Hz, H3b), 5.40 (lH, dd, J = 3.1, 13.0 Hz, H2), 5.99 (lH, d, J = 
1.9 Hz, H8), 6.01 (lH, d, J = l.9 Hz, H6), 7.42 (SH, m, B-ring protons). 
13C-NMR (CDCl3, 75.5 MHz) 8: 43.0 (C3), 78.9 (C2), 95.4 (CB), 96.3 (C6), 102.2 
(ClO), 125.9 (C2', C6'), 128.6 (C3', C4', CS'), 138.2 (Cl'), 162.9 (CS), 163.7 (C7), 
166.7 (C9), 195.5 (C4). 
14-Hydroxy-6-caryophyllene (3.12) 
Colorless oil. [a]o: -14.2 °, c = 0.0076 in CHCl3 (Lit189: -13.5 °). 
EIMS m/z (0/o): 220 (7) [M]+, 205 (32) [M-Me]+, 202 (18) [M-H20]+, 187 (8) 
[M-Me-H20]+, 164 (7) [M-isobutylene]+, 133 (25), 119 (18), 105 (33), 91 
(63), 79 (69), 69 (100), 56 (72) [C4H8]+. 
HR-EIMS: m/z 220, found 220.1829. C14H210 requires 220.1827. m/z 205, 
found 205.1595. C14H210 requires 205.1592. 
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lH-NMR (CDCl3, 300 MHz) 8: 3.70, 3.92 (lH, d, J = 11.2 Hz, H14a), 4.19, 4.12 
(lH, d, J = 11.2, H14b), 4.78, 4,90 (lH, s, HlSa), 4.96, 5.08 (lH, s, HlSb), 5.39, 
5.45 (lH, dd, J = 4.5, 10.7 Hz and J = 5.4, 10.9 Hz, HS). 
13C-NMR (CDCl3, 75.5 MHz) 8: 56.9, 56.9 (Cl), 29.2, 30.0 (C2), 42.6, 40.6 (C3), 
137.7, 137.9 (C4), 128.8, 129.5 (CS), 30.5, 30.5 (C6), 33.8, 34.9 (C7), 153.9, 158.9 
(C8), 49.1, 49.7 (C9), 40.3, 40.3 (ClO), 32.9, 32.9 (Cll), 29.8, 30.0 (Cl2), 22.1, 
21.9 (C13), 60.2, 62.0 (C14), 110.1, 113.1 (ClS). 
4,5-~oxy-13-hydroxy-6-caryophyllene (3.13} 
Colorless oil. [a]D: - 64.1 °, c = 0.0086 in CHCl3. 
EIMS m/z (0/o): 221 (1) [M-Me]+, 205 (7) [M-CH20H]+, 159 (21), 147 (28), 
135 (29), 119 (60), 107 (92), 84 (100), 79 (28), 55 (23). 
CIMS (NH3)m/z (0/o): 237 (19) [M+H]+, 219 (58) [M+H-H20]+, 201 (100) 
[M+H-H20]+, 191 (19), 161, (37), 145 (29), 134 (23), 121 (30), 109 (42). 
HR-EIMS: m/z 221, found 221.1538. C14H2102 requires 221.1542. m/z 205, 
found 205.1593. C14H210 requires 205.1592. 
lH-NMR (CDCl3, 500 MHz) 8: 0.95 (lH, ddd, J = 5.5, 12.7, 13.3 Hz, H3a), 1.06 
(3H, s, Hl2), 1.20 (3H, s, H14), 1.33 (lH, dddd, J = 5.0, 7.5, 10.5, 12.4 Hz, H6a), 
1.54 (lH, dddd, J = 4.1, 10.3, 13.3, 14.8 Hz, H2a), 1.60 (lH, dd, J = 11.0, 11.4 
Hz, HlOa), 1.85 (lH, dddd, J = 1.3, 3.3, 5.5, 14.8 Hz, H2b ), 1.91 (lH, ddd, J = 
1.3, 8.5, 10.3 Hz, Hl), 1.96 (lH, dd, J = 8.8, 11.4 Hz, HlOb ), 2.08 (lH, ddd, J = 
3.3, 4.1, 12.7 Hz, H3b), 2.10 (lH, ddd, J = 0.8, 7.5, 13.0 Hz, H7a), 2.24, (lH, 
dddd, J = 0.8, 4.5, 7.3, 12.4 Hz, H6b), 2.36 (lH, ddd, 5.0, 7.3, 13.0 Hz, H7b), 
2.67 (lH, ddd, J = 8.5, 8.7, 11.0 Hz, H9), 2.86 (lH, dd, J = 4.5, 10.5 Hz, HS), 
3.52 (lH, d, J = 10.8 Hz, H13a), 3.68 (lH, d, J = 10.8 Hz, H13b ), 4.90 (lH, d, J = 
1.6 Hz, HlSa), 5.02 (lH, d, J = 1.6 Hz, HlSb). 
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13C-NMR (CDCb, 75.5 MHz) 8: 16.9 (Cl2), 24.9 (Cl3), 26.2 (C2), 29.8 (C6), 
30.1 (C7), 35.2 (ClO), 38.6 (Cll), 39.3 (C3), 48.3 (C9), 51.4 (Cl), 59.7 (C4), 63.6 
(CS), 66.9 (C14), 113.0 (C15), 151.7 (C8). 
Synthesis of 4,5-epoxy-14-hydroxy-iso-caryophyllenes (3.16 and 3.17) 
To ~-caryophyllene (1 g = 4.9 mmol) in methanol (10 ml) was added 
selenium dioxide (550 mg = 5 mmol) and the mixture stirred for 4 h. 
Celite (3 g) was added and the solvent evaporated in vacuo. Purification 
by VLC eluted with dichloromethane yielded is&aryophyllene (351 mg, 
35°/o) and 14-hydroxy-iso-caryophyllene (321 mg, 30°/o). 
To 14-hydroxy-iso-caryophyllene (204 mg = 1 mmol) 1n 
dichloromethane was added m-chloroperbenzoic acid (380 mg = 1.2 
mmol) and the mixture stirred until TLC showed complete conversion 
of starting material (1 h.). The dichloromethane solution was washed 
with 10°/o aq. sodium sufite (10 ml) and water (10 ml), dried and 
evaporated. Repeated flash column chromatography on silica eluted with 
dichloromethane / ether (90: 10) gave pure a-epoxide (110 mg) and ~-
epoxide (25 mg). 
E. ~ 
6-4,5-tpoxy-14-hydrox~!}socaryophyllene (3.16) 
colorless waxy needles mp: 108-10 °C 
[a]o: + 48.4 °, c = 0.028 in CHCb. 
EIMS m/z (0/o): 236 (6) [M]+, 218 (4) [M-H20]+, 205 (26) [M-CH20H]+, 187 
(35) , 175 (23), 161 (27), 147 (36), 131 (47), 121 (61), 107 (82), 93 (95), 79 (100), 
69 (86). 
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HR-EIMS: m/z 236, found 236.1780. C1sH2402 requires 236.1776. 
lH-NMR (CDCb, 500 MHz) 8: 0.92 (Me12), 0.98 (Me13), 1.40 (H6a), 1.42 
(H3a), 1.51 (H2a), 1.52 (H2b ), 1.56 (HlOa), 1.82 (HlOb ), 1.86 (Hl), 1.97 (H3b ), 
2.19 (H7a), 2.28 (H6b), 2.12 (H7b), 2.47 (H9), 2.96 (HS), 3.43 (H14a), 3,71 
(Hl4b ), 4.78 (HlSa), 4.81 (HlSb) 
13C-NMR (CDC!J, 75.5 MHz) 8: 22.7 (C12), 23.4 (C3), 24.0 (C2), 26.9 (C6), 30.0 
(Cl3), 30.2 (C7), 33.5 (Cll), 38.0 (C9), 40.8 (ClO), 48.7 (Cl), 60.5 (CS), 63.2 (C4), 
63.6 (C14), 111.1 (ClS), 154.2 (CS). 
a-4,S-jpoxy-14-hydrox)@socaryophyllene (3.17) 
colorless waxy needles mp: 72-75 °C 
[a]D: - 21.5 °, c = 0.007 in CDCl3. _ 
EIMS m/z (0/o): 336 (7) [M]+, 218 (17) [M-H20]+, 205 (45) [M-CH20H]+, 
187 (46), 175 (35), 161 (37), 149 (66), 131 (46), 121 (52), 106 (100), 93 (73), 79 
(69), 69 (47). 
HR-EIMS: m/z 236, found 236.1774. C1sH2402 requires 236.1776. 
lH-NMR (CDCl3, 500 MHz) 8: 0.99 (Mel2), 1.01 (Me13), 1.28 (H3a), 1.33 
(H2a), 1.56 (H2b), 1.58 (HlOa), 1.63 (H6a), 1.74 (HlOb), 1.81 (Hl), 2.15 (H6b), 
2.20 (H3b ), 2.31 (H7a), 2.58 (H7b ), 2.61 (H9), 3.00 (HS), 3.52 (H14a), 3.79 
(H14b ), 4.70 (HlSa), 4.82 (HlSb ). 
13C-NMR (CDCl3, 75.5 MHz) 8: 21.5 (C12), 24.0 (C2), 24.9 (C3), 28.9 (C6), 29.4 
(C7), 29.8 (C13), 34.5 (Cl l), 40.5 (ClO), 44.2 (C9), 50.6 (Cl), 61.0 (CS), 63.9 (C4), 
64.6 (Cl4), 112.8 (ClS), 150.2 (C8). 
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13-(4-Bromo-3,5-dinitrobenzoyloxy)-(4R,5R)-epoxy-~-caryophyllene (3.21) 
To the caryophyllene 3.9 (6 mg = 0.03 mmol) and pyridine (3 mg = 
0.035 mmol) in dry ether (10 ml) at O °C, was added 4-bromo-3,5-
dinitrobenzoylchloride (9 mg = 0.031 mmol) with stirring. Stirring was 
continued until complete disappearance of starting material (TLC). Celite 
(2 g) was added and the volatiles removed in vacuo. Purification by VLC 
on silica eluted with hexane/ ethyl acetate (90:10) to give 3.17 (12 mg = 
91 °/o). 
Light yellow oil. [a]n: - 23 °, c = 0.003 in CHCl3, 
EIMS m/z (0/o): 508/509 (4) [M]+, 480/482 (8/9), 464/466 (11/13) [M-C02]+, 
272/274 (63/65) [C7H2N20sBr]+, 226/228 (49/52) [C7H2N20sBr-N02]+, 205 
(37), 175 (39), 159 (52), 133 (57), 105 (76), 93 (95), 79 (100). 
HR-EIMS: m/z 508, found 508.0846. C22H2sN20779Br rquires 508.0845. 
m/z 510, found 510.0892. C22H2sN20~lBr requires 510.0825. 
lH-NMR (CDCb, 500 MHz) o: 0.88 (H2a), 1.00 (H3a), 1.19 (3H, Mel2), 1.21 
(Me14), 1.36 (H6a), 1.55 (H2b), 1.74 (HlOa), 1.83 (H3b), 2.01 (HlOb), 2.05 (Hl), 
2.13 (H7a), 2.27 (H6b), 2.38 (H7b), 2.74 (H9), 2.86 (HS), 4.42 (H13a), 4.53 
(H13b ), 4.96 (HlSa), 5.06 (HlSb ). 
13C-NMR (CDCl3, 75.5 MHz) o: 16.9 (C12), 25.2 (C14), 26.5 (C2), 29.8 (C6), 
30.1 (C7), 35.4 (ClO), 37.4 (Cll), 39.1 (C3), 48.4 (C9), 51.1 (Cl), 59.2 (C4), 63.4 
(CS), 70.9 (C13), 112.4 (C4'), 113.8 (C15), 127.5 (C2',C6'), 132.0 (Cl'), 150.7 
(C8), 151.5 (C3',5'), 162.3 (CO). 
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Pycnoporus • coccineus 
Pycnoporus coccineus is a bright scarlet to vermillion woodrotting 
fungus which is widespread in temperate areas of Australia. It has been 
used as a remedy to treat mouth sores by Australian aborigines of the 
Pintu and Pitjantjatjara tribes.153 It has also been used by them as 
"teething rusks" for babies with teething problems,153 probably because of 
the corklike, rubbery texture of the fresh fungus. 
Pycnoporus coccineus 
Bioautography on TLC traces of the crude extracts showed the 
antibiotic activity to be associated with the pigments in the fungus and 
two active phenoxazine derivatives 3.22 and 3.23 were subsequently 
isolated. 
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16 
CHO C02H 
8 
NH2 
7 0 0 
6 4 
3.22 3.23 
Isolation and structure elucidation. 
Due to very dry weather conditions experienced at the time of 
collection it was not possible to obtain sufficient natural material for a 
phytochemical investigation. It was decided to attempt to cultivate the 
fungus in the lab. From a fresh specimen of P. coccineus, viable spores 
were obtained and the fungus cultivated.* The fungal mycelium was 
extracted and purified according to Scheme 3.5 
Considering TLC experiments showed that 3.22 is less polar than 
3.23, and was found to be more soluble in dichloromethane, it is 
interesting to note that it is present in the more polar ethyl acetate 
extract. This could indicate that 3.23 is an artefact arising from a 
transesterification of 3.24 with the solvent. 
* 
0 
3.24 
0 
The author gratefully acknowledges Judith Curnow from The Australian National 
Botanic Gardens for collecting the fresh specimen and Margaret Anderson for cultivating 
the fungus. 
Chapter Three 
Pycnoporus coccineus 
Mycelium 
heptane 
PC-1 
(499 mg) 
VLC on silica 
PC-2 
(658 mg) 
active 
heptane /EtOAc 50:50 ---t 0:100 
PC-2C 
(166 mg) 
CTLC on silica 
CH2Cl2/MeOH 98:2 ---t 90:10 
Washing with ether 
PC-2Cl 
(36 mg) 
3.22 
(31 mg) 
Extraction 
EtOAc 
PC-3 
(683 mg) 
active 
VLC on silica 
MeOH 
PC-4 
(7.6 g) 
heptane /EtOAc 50:50 ---t 0:100 
PC-3B 
(105 mg) 
CTLC on silica 
CH2Cl2/MeOH 98:2 ---t 90:10 
PC-3B2 
(11 mg) 
3.23 
(9 mg) 
Washing with ether 
Scheme 3.5 Extraction and purification of pigments from P. coccineus 
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A survey of the literature revealed that pigments had been isolated 
from several red bracket fungi similar to P. coccineus albeit under 
different names. P. coccineus was previously known as Trametes 
cinnabarina and Polystictus cinnabarinus, which are the names used in 
the publications describing previous chemical investigations. Taxonomic 
investigations have presented genetic and morphological evidence 
supporting the validity of classifying Pycnoporus as three distinct 
species.199 
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The compounds 3.22, 3.23 and 3.24 have previously been 
described~oo,201,202 In the earlier studies the di-acid 3.25, which is almost 
certainly the biogenetic precursor of 3.22, 3.23 and 3.24, was also 
isolated.200 The di-acid has also been shown to be the major free pigment 
of red kangaroo (Megaleia ruf a) hair. 203 
3.25 
In the present study the compounds 3.22 and 3.23 were identified by 
their molecular formulas obtained from HR-EIMS experiments and 
comparison of their physical and spectral data with those previously 
published for 3.22 and 3.23. No NMR data has been published for 3.22 and 
3.23 mainly because the earlier studies were performed before the advent 
of NMR spectroscopy. One recent paper, however, has presented data for 
several methyl esters201 which were in agreement with data obtained for 
3.22 and 3.23. 
Experimental 
Isolates of P. cocczneus from a sporophore after drying were 
cultivated in Petri dishes on a range of media of which corn meal agar 
turned out to be the best. 
Half a plate of the cultivated fungus was macerated in distilled 
water (10 ml) and added to a 4 °/o corn meal broth. The inoculated broth 
was transferred to 10 penicillin flasks and left to incubate at 25 °C. 
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After 42 days the growth seemed to have stagnated and the 
fermentation was stopped, the orange mycelium mats removed from the 
penicillin flasks, placed in a Buchner funnel and pressed to remove most 
of the water trapped in the mat. 
Samples from the filtrate and the mycelium mats were tested using 
the previously described bioassay (p. 37) and the activity found to be a 
associated with the mycelium. 
The mycelium was macerated with heptane (1 L) in a blender and 
the pulp left extracting overnight. This was repeated with 3x 1 L heptane 
and subsequently with dichloromethane, ethyl acetate and methanol to 
give PC-1 (499 mg), PC-2 (658 mg), PC-3 (683 mg) and PC-4 (7.6 g). 
The four crude extracts were analysed by TLC and the TLC plates 
used for the bioautography of the four extracts. The activity was found to 
be concentrated in the extracts PC-2 and PC-3 containing the yellow-
orange pigments. 
PC-2 was fractionated by VLC on silica gradient eluted with 
heptane/ethyl acetate (50:50 ~ 0:100). The fractions containing the 
pigment PC-2C was subsequently purified using centrifugal TLC eluted 
with dichloromethane/methanol in three steps (98:2, 95:5 and 90:10). 
Proton NMR showed the pigment to be contaminated with lipid material 
which could be removed by washing the orange solid with ether to give 
3.22 (31 mg, 0.005 °/o). 
PC-3 was fractionated and purified using a sequences identical to the 
one described above giving 3.23 (9 mg, 0.002 °/o). 
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A 
2-~mino-3-oxo-1-formyl-3H-phenoxazine-9-carboxylic acid (3.22) 
orange-brown microcrystalline solid. mp: >300 °C. ~ it.204 mp: >250 °C .) 
UV-VIS (Amax, nm): 240, 261, 434, 461. 
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EIMS m/z (0/o): 284 (52) [M]+, 256 (92) [M-CO]+, 238 (100) [256-H20]+, 212 
(60) [256-C02]+, 76 (43) [benzyne]+. 
HR-EIMS: m/z 284. Found 284.0429. C14HsN20s requires 284.0433. 
m/z 256. Found 256. 0487. C13HsN204 requires 256.0484. 
lH-NMR (300 MHz, DMS0-d6) 8: 6.61 (lH, s, H4), 7.73 (lH, ddd, J = 1.2, 
7.5, 8.1 Hz, H8), 7.85 (lH, dd, J = 1.2, 8.1 Hz, H7), 7.98 (lH, dd, J = 1.2, 7.5 Hz, 
H9), 10.33 (lH, s, H14). 
13C-NMR (75.5 MHz, DMS0-d6) 8: 92.8 (Cl), 105.2 (C4), 121.9 (C6), 128.5 
(C8), 129.0 (C9), 129.2 (C7), 131.5 (Cll), 142.3 (C2), 148.8 (C14), 150.7 (C13), 
152.8 (C12), 169.0 (C15), 178.1 (C3), 191.7 (C16). 
2-~mino-3-oxo-9-hydroxymethyl-3H-phenoxazine-1-carboxylic acid (3.23) 
orange microcrystalline solid. mp: 265-70 °C.(Lit.ll mp: 250-52 °C.) 
UV-VIS (Amax, nm): 240,261,431,453. 
EIMS m/z (0/o): 328 (41) [M]+, 284 (28) [M-C02]+, 267 (20), 224 (100) [284-
CH3COOH]+, 77 (15) [phenyl]+. 
HR-EIMS: m/z 328. Found 328.0704. C16H12N206 requires 328.0695. 
m/z 284. Found 284.0793. C1sH12N204 requires 284.0797. 
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lH-NMR (300 MHz, DMS0-d6) 8: 2.06 (3H, s, COMe), 5.39 (2H, s, Hl3), 
6.63 (lH, s, H4), 7.58 (3H, H6, H7, H8). 
13C-NMR (75.5 MHz, DMS0-d6) 8: 20.4 (COMe), 60.7 (C15), 92.4 (Cl), 105.1 
(C4), 116.6 (C6), 126.3 (C8), 128.1 (Cll), 129.2 (C7), 131.4 (C9), 142.3 (C2), 
146.8 (C14), 150.9 (C13), 152.2 (C12), 168.8 (COMe), 170.0 (C16), 177.8 (C3). 
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CHAPTER FOUR 
SYNTHESIS OF DONAXARIDINE 
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Introduction 
The oxindole alkaloids are a subgroup of the larger group of indole 
alkaloids. They can be divided into two major classes based on the 
complexity of their structure. Most of the complex alkaloids are based on 
skeletons such as that of isocaboxine 4.1, uncarine 4.2, alstonisine 4.3 and 
gelsemine 4.4.1 and are derived from condensation of tryptamine with a 
monoterpene like secologanin. 2 
H 
4.1 4.2 
4.3 4.4 
Little has been done to shed light on the biosynthesis of oxindole 
alkaloids. Most of the insights have come from synthetic and 
biosynthetic studies on indole alkaloids, which co-occur with the 
oxindoles. Results from these studies seem to suggests that complex 
oxindole alkaloids arise from rearrangements of oxidised indole alkaloid 
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intermediates3,4 and occur late in the biosynthesis as illustrated in Fig. 
4.1. 
OMe OMe 
MeO MeO 
... ... 
N 
0 0 
/ 
H 
MeO 
MeO 
Fig. 4.1 
One class of simple oxindole alkaloids contains a hydroxy 
substituent at the tertiary benzylic carbon a to the oxindole carbonyl (4.5-
4.12). It is interesting to note that the majority of these compounds exist 
as racemic mixtures or mixtures of epimers at that centre e.g. compounds 
4.5-4.9.5,6,7,8,9 This seems to suggest that they could be formed by an 
autoxidation process and may or may not be artefacts produced during 
isolation of the alkaloids. A few optically active alkaloids of this type 4.10-
4.12, however, have been reported.10,11,12 
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Many simple indole derivatives are known for their biological 
activity, in particular they display different kinds of activity on the 
central nervous system (e.g serotonin, N,N-dimethyltryptamine, 
psilocybin). Oxindoles 4.8, 4.10 and 4.11 have been reported to possess 
antibiotic activity8,10,ll and 4.12 has shown tumor promoting activity.12 
Compounds possessing the indolin-2-one moiety have also shown 
activity as non-steroidal cardiotonics,13 anaesthetic agents,14 in addition 
to anticonvulsantlS,16 and insecticidal activity .17 
Compound 4.5 known as donaxaridine was chosen as a synthetic 
target as it is a representative of the 3-hydroxylated oxindoles. Because it 
also contained an aminoethyl sidechain, it was considered a possible 
useful intermediate in the synthesis of oxindole alkaloids. The synthesis 
of 4.5 was undertaken with the underlying strategy of using inexpensive 
starting materials and simple reactions. 
Previous indolin-2-one syntheses 
Several approaches have been taken to the synthesis of 3-substituted 
indolin-2-ones. Indolin-2-one itself, and its 3-alkyl derivatives have been 
prepared by Friedel-Craft methods from the appropriate anilidesl8,19 and 
by cyclisation of ~-acylphenylhydrazines20,21 (Fig. 4.2). 
Other methods of synthesis of indolin-2-ones include lactamisation-
o-trtho-aminophenylacetates, which has been used in particular for 
derivatives substituted in the aromatic ring. The appropriate 
phenylacetates are synthesised from nitrotoluenes22 by homologation 
and reduction, and from halogenated nitrobenzenes23 by nucleophilic 
aromatic substitution (Fig. 4.3). 
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ClCHR1 CCX] 
0 
Fig. 4.2 Cyclisation using Friedel-Craft and similar methods 
R-©(02 (C02Et)i, base C02H Hydrol. 
Hz02 ! base 
C02H 
Zn H+ 
~ N02 
0 
~ 
Fe,H + C02Me 
N02 
~iCI I 
C02Me R-©(Hal NaH, CH2(C02Me)i C02Me 
N02 
Fig. 4.3 Lactamisation of nitrophenyl acetates 
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Claisen and Knoevenagel condensations of indolin-2-one with a 
variety of esters and aldehydes have also been utilised for the synthesis of 
3-substituted indolin-2-ones24,25,26 (Fig. 4.4). 
0 a. RC02Me, base 
b. H2, Pd(C), H+ 
0 
a. RCHO, base 
b. H2, Pd(C) 
Fig. 4.4 Claisen and Knoevenagel condensations of indolin-2-one 
More recent approaches to 3-substituted indolin-2-ones have 
utilised oxidation of the corresponding indoles with DMSO /HC127 or 
NBS28 (Fig. 4.5); Horner-Wadsworth-Emmons (HWE) olefination of 
isatin with triethylphosphonoacetate29 (fig. 4.6); radical cyclisation of 
bromoanilides30,31 (Fig. 4.7); or cyclisation of a-diazoanilides32 (Fig. 4.8). 
0 
DMSO, HCl 
or NBS 
Fig. 4.5 Oxidation of oxindoles 
0 
(EtO)iPOCH2C02Et 
NaH 
Fig. 4.6 Horner-Wadsworth-Emmons olefination 
0 
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Indolin-2-ones with a hydroxy substituent at C3 have been 
synthesised directly from isatins with organometallic reagents29,33 or by 
aldol condensation with activated methylene compounds34 (Fig. 4.9) . 
MeO"©lr ~ 
N 
I 
SEM 
MeO 
Fig. 4.7 Radical cyclisation of bromo anilide. 
Fig. 4.8 Cyclisation by carbene insertion. 
0 HO 
0 
Fig. 4.9 Synthesis of 3-hydroxyindolinones. 
0 
Indolin-2-ones have recently been functionalised at the 3-position 
using a 1,3-dipolar cycloaddition of a nitrogen ylide to 3-methylene-
indolin-2-one generated by flash vacuum pyrolysis35 (Fig. 4.10). 
Fig. 4.10. 1,3-dipolar cycloaddition of nitrogen ylids. 
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Alkylation of indolin-2-ones with a substituent on C3 and the 
lactam nitrogen has been used to make 3,3-disubstituted indolin-2-ones 
and was a key step in Julians synthesis of eserethole.36 
EtO 
(-)-eserethole 
Alkylation of indolin-2-ones and other 1,3,3 unsubstituted indolin-
2-ones, however, does not proceed satisfactorily. Alkylation of indolin-2-
one itself leads to varying amounts of C-3 and N-substituted products 
and kinetic studies have shown that C-3 alkylation is three times as fast 
as N-alkylation.37 Once alkylated the hydrogen at C-3 is even more 
reactive alkylating thirty times faster than· on the nitrogen.37 
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Synthesis of donaxaridine 
Donaxaridine 4.5 was isolated in 1976 from the giant reed Arundo 
donax along with donaxarine 4.13 and other simple indole alkaloids.5 
0 
4.13 
Two convergent routes to 4.5 were envisaged starting from the 
readily available indolin-2-one with direct incorporation of the secondary 
amine sidechain (Fig. 4.11 and Fig. 4.12). 
4.5 
+ 0 
R =Hor Ac 
H R 
N"-
" NR 
Fig. 4.11 Retrosynthetic analysis based on a Claisen condensation. 
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4.5 
+ 
R = Ts or CBz 
R 
N, 
0 
' NR 
126 
0 
Fig. 4.12 Retrosynthetic analysis based on a Knoevenagel condensation. 
In addition to the convergent syntheses of 4.5 several linear 
syntheses were postulated in which the amine sidechain was elaborated 
from a appropriate indolin-2-one precursor (Fig. 4.13). 
The two syntheses based on the Claisen and Knoevenagel 
condensations in Fig. 4.11 and 4.12 were the most attractive because of the 
availability of the starting materials and the short reaction sequences. 
Condensations of indolin-2-one with N,N-dialkylglycines38 and N-
acetylglycine25 have been reported, but no yields were quoted for the 
N,N-dialkylglycine condensation. 
Attempts to condense indolin-2-one with both N-methylglycine 
ethyl ester (R = H in Fig. 4.11) and N-acetyl-N-methylglycine ethyl ester 
(R = Ac in Fig. 4.11) using sodium ethoxide in ethanol as specified38,25 
were unsuccessful since only starting material was recovered from the 
reaction mixture. The reactions were repeated using combinations of 
different bases and solvents (e.g. NaH/DMF, NaH/THF), but without 
success. 
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Fig. 4.13 Linear retrosynthesis of 4.5 
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Attention was then focussed on the Knoevenagel condensation (Fig. 
4.12) although the a-amino aldehyde necessary for the reaction was not 
as readily available as the aminoacid esters. A model study using indolin-
2-one and acetaldehyde was performed first, in order to find the mildest 
conditions for the condensation. Recently organic reactions carried out 
on an inorganic support have received considerable attention.39,40 
Alumina, either alone or doped with weak bases like fluoride ions, has 
been shown to be an excellent catalyst for condensations involving 
activated methylene compounds. 
Indolin-2-one was condensed with acetaldehyde in THF or 
dichloromethane using five equivalents of alumina to give a 1:1 mixture 
of ethylidene indolin-2-ones 4.14 and 4.15. These in turn were readily 
reduced to 3-ethylindolinone 4.16 with sodium borohydride in ethanol 
or by hydrogenation (Pd/C, methanol). 
0 0 0 
4.14 4.15 4.16 
The type of alumina (acidic, neutral, basic) used did not appear to 
matter and the reactions were usually complete after stirring overnight at 
room temperature in yields exceeding 90 °/o. 
Since this reaction worked so well in the model study it was 
subsequently used to prepare the two pigments 4.17 and 4.18, isolated 
from the rhizomes of Cimicifuga dahurica.41 Using the alumina method 
4.17 and 4.18 were obtained as a 19:2 mixture in 85 °/o yield from indol-2-
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one and 3-methylbutenal. These pigments have previously been 
synthesised as a 3:1 mixture in 15 °/o yield using Wittig chemistry.41 
0 
4.17 4.18 
Although the model studies showed promise, the introduction of 
an acylamino substituent a to the aldehyde function led to a marked 
difference in reactivity. In addition to some indolin-2-one only 
intractable polar material was recovered from the reaction of a-
bezyloxycarbonylaminoacetaldehyde in THF using basic alumina as 
catalyst. This is likely to be due to the increased tendency of the starting 
material to polymerise. 
Since attempts to synthesise 4.5 by the convergent routes were 
unsuccessful it was decided to pursue the linear approach in spite of the 
added number of steps. The first step, a two carbon homologation at the 
3-position to the key intermediate ethyl oxindolylacetate 4.20, was 
initially achieved using Julian's method of condensing indolin-2-one 
with diethyl oxalate followed by reduction24 (Fig. 4.4). 
H 
4.20 
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It was, however, difficult to purify the product and the yields could not be 
reproduced so another method for the praparation of 4.20 was developed. 
Ethyl isatylideneacetate 4.21 had previously been prepared by 
Horner-Wadsworth-Emmons (HWE) olefination of isatin26 (Fig. 4.6). 
Because of the acidic hydrogen on the lactam nitrogen on the 
unprotected indolin-2-one, yields were poor using the strongly basic 
standard conditions (NaH, THF) and a more recent variation of the 
reaction was adopted. HWE reactions have been found to proceed 
smoothly under mild conditions using lithium bromide and 
triethylamine in THF at room temperature or below.42,43 which do not 
require rigorous exclusion of moisture. Using this method ethyl 
isatylidene acetate 4.21 could be prepared consistently in -80 °/o yield. This 
was then hydrogenated to give 4.20. 
In addition to 4.21, 5-10 °/o of a polar biproduct was always produced, 
increasing with the temperature. This compound was identified as 4.22, 
that is, the Michael adduct of triethyl phosphonoacetate 4.18 with the 
HWE product 4.21, by high resolution mass spectrometry, micri)nalysis 
and the fact that the three signals at o 44.6, 45.3 and 47.0 ppm in the APT-
spectrum of 4.17 (illustrated by •) all corresponded to methine carbons. 
0 
4.21 4.22 
~' /OEt 
P-oEt 
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Ethyl oxindolyl acetate 4.20 was then reduced smoothly to oxindolyl 
acetaldehyde 4.23 in 82 °/o by reduction with diisobutylaluminiumhydride 
(DIBAL-H) in dichloromethane at -78 °C. It is interesting to note that 
considering the amount of work which has been done on the synthesis of 
indole alkaloids, this aldehyde has not been previously described before. 
H H OH 
4.23 4.24 
The other proposed intermediate in the elaboration of the sidechain 
3-hydroxyethylindolin-2-one 4.24, was readily prepared by reduction of 
the aldehyde with sodium borohydride in ethanol. Direct ester to alcohol 
reductions in the presence of amide functionalities have been described 
using calcium borohydride in ethanol,44 lithium borohydride in THF 
with one equivalent of methanol added45 and sodiurryborohydride in 
t-butanol at reflux.46 Although all these methods did reduce the ester 4.20 
it was found that using alcoholic solvents or adding methanol to the 
reaction mixture resulted in overfaeduction to tryptophol 4.25 and 
complex mixtures, probably because the in situ formed 
alkoxyborohydrides are more powerful reducing agents. It was eventually 
found that using excess lithiunf,orohydride (5 eq.) in THF at reflux, 
without the addition of methanol, consistently gave 3-
hydroxyethylindolin-2-one 4.24 in -80 °/o yield. In addition to the alcohol 
4.24, tryptophol 4.25 was always formed in 2-5 °/o yield and could be 
identified by comparison with authentic material. 
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OH 
4.25 
Reductive amination of the aldehyde 4.23 with methyl amine, using 
sodiunf:yanoborohydride or hydrogenation over Pd/C in the presence of 
molecular sieves, were both unsuccessful. Although the starting material 
disappeared quickly only intractable highly polar material was produced. 
An attempt was then made to introduce the methylamino group 
in the sidechain by substitution of the tosylate of the alcohol 4.24. Upon 
reaction of 3-hydroxyethylindolin-2-one 4.24in THF with one equivalent 
of tosyl chloride in the presence of triethylamine, the alcohol was 
smoothly converted to a new compound in 95 °/o yield. The lH-NMR and 
APT spectra of this compound showed no signal corresponding to a tosyl 
group. Apart from the indolin-2-one signals only one other carbon and 
an A2B2 system at o 1.55 and 1.78 ppm were present. This suggested that 
the product was the 3-spirocyclopropyl-indolin-2-one 4.26 which was 
subsequently confirmed by comparison with data published for this 
compound47 (Fig. 4.14) 
0 
4.2t 
Fig. 4.14 Cyclisation of the tosylate. 
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A survey of the literature showed that 3-spirocyclopropylindolin-2-
one 4.26 is readily formed from 4.24 under acidic conditions as well.48 In 
view of the ease with which 3-alkylated indolin-2-ones undergo further 
alkylation at C3 it was expected that introduction of any leaving group at 
the C2' position would lead to intramolecular alkylation to give 4.26. 
Introduction of the hydroxy substituent at the benzylic position at 
this time in the synthesis appeared to be one way to circumvent this 
r"\. problem. Having prepared the 3-ethylbndolinone 4.16_,it was used as a 
model for the introduction of the hydroxy substituent at the benzylic 
position of the indolin-2-one. 
Insertion of an acetoxy group into activated methylene compounds 
has been observed as a reaction biproduct in oxidative radical 
cyclisations using manganese triacetate.49 This insertion was achieved by 
treatment of 4.16 with two equivalents of manganese triacetate in 
refluxing glacial acetic acid to give 3-acetoxy-3-ethyl-indolinone 4.27 
cleanly in 87 °/o yield (Fig. 4.15). 
AcO 
0 
Mn(OAc)i 
AcOH, ~ 
4.16 4.27 
Fig. 4.15 Manganese triacetate oxidation of 3-alkylated indolin-2-one 
~ 
Oxidation of 3-hydroxyethy!tjndolin-2-one 4.24 with manganese 
triacetate, however, did not proceed satisfactorily and resulted in a 
complex mixture of compounds. Considering the rather vigorous 
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reaction conditions (glacial acetic acid, reflux) this 1s perhaps not 
surpnsmg. 
Another method used to introduce a functionality at the 3-position 
of indolin-2-ones utilises bromination at the benzylic position followed 
by substitution with appropriate nucleophiles (e.g. OH-, Meo-, 
HNMe2)SO (Fig. 4.16) 
0 .. 0 .. 0 
Fig. 4.16 Introduction of substituents at C3. 
Bromination of 3-hydroxyethyl-indolin-2-one 4.24 with bromine in 
dichloromethane was less satisfactory because of the preferred formation 
of 3-spirocyclopropylindolin-2-one 4.26 (60 °/o). Protection of the primary 
alcohol via the acetate was carried out to alleviate this problem. Because 
of the reactivity of the benzylic position the alcohol was acylated by 
enzymatic transesterification using a lipase from Candida antarctica 
(NOVO SP-435). With the enzymatic transesterification no purification is 
needed. Filtration of the immobilised enzyme and evaporation of 
solvent gave pure acetate 4.28 in quantitative yield. 
H 
OAc 
4.28 
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Bromination of the acetate 4.28 gave one product,as shown on TLC, 
which was converted directly to the the hydroxy compound 4.29, in 93 °/o 
yield after chromatography, by evaporation of the solvent and stirring it 
with 50 °/o aqueous t-butanol containing 5 °/o sodium carbonate. Isolation 
of the bromo compound was not attempted because it showed 
considerable decomposition on the TLC plate. It was thought that 
purifying the bromo compoundon a silica column would lead to loss of 
material. Deprotection of the primary alcohol was achieved without 
complications by treatment of 4.29 with 0.5 °/o sodium methoxide in 
methanol to give the diol 4.30 in quantitative yield. 
HO OAc HO OH 
4.29 4.30 
To finish the synthesis of donaxaridine 4.5 the primary hydroxyl 
had to be converted to a good leaving group and displaced by 
methylamine. Because the two hydroxyls in 4.30 were different it was 
assumed that the primary hydroxyl would react much faster with tosyl 
chloride. 
Reaction of the diol 4.30 with one equivalent of tosyl chloride in 
THF in the presence of triethylamine proceeded very slowly. Repeating 
the reaction in neat pyridine, however, gave complete conversion to the 
primary tosylate 4.31 in 95 °/o yield. 
The final displacement of the tosylate was achieved by reacting it 
with 50 equivalents of methylamine in methanol at reflux , giving 
donaxaridine 4.5 in 89 °/o yield which ~ identical in all respects to the 
compound isolated by Ubaidulaev.5 
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4.31 
HO 
4.5 
H 
N'-..... 
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The synthesis of donaxaridine 4.5 (Fig. 4.17) was achieved using 
readily accessible reagents and starting materials. Apart from the acetate 
4.28 no protecting groups were necessary to complete the synthesis. 
H 
4.240 
HO 
4.29 
a. (EtO)iPOCH2C02Et 0 .. 
b. H 2, Pd/C 
OH 
OAc 
vinylacetate 
lipase 
MeO-,MeOH 
H 
4.20 
H OAc 
4.28 
OH 
4.30 
Fig. 4.17 Total synthesis of donaxaridine 4.5. 
THF 
TsCl 
pyridine 
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HO 
OTs HO H N "--
exc. MeNH2 
MeOH 
4.31 4.5 
Fig. 4.17 cont. Total synthesis of donaxaridine 4.5. 
Several of the early intermediates in the synthesis could prove 
useful in the synthesis of indole and oxindole alkaloids. Physostigmine 
~s k>e1n9 
derivatives with substituents in the C ring can be envisaged/synthesised 
from the product obtained by a Claisen condensation of indoline-2-ones 
with an oxygen substituent at the 5-position and diethyl oxalate (Fig. 
4.18). 
RO 
RO 
________ ,.. 
________ ,.. 
________ ,.. 
(cond.) 0 ________ ,.. 
(alk.) 0 ________ ,.. 
RO 
(red.) 
________ ,.. 
OH 
RO 
________ ,.. 
HO 
RO 
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Likewise if ethyl isatylidene indoline-2-one 4.21 can be used as an 
acceptor in Michael condensations, as the formation of the b(product 4.22 
in the HWE reaction suggests, it opens a range of possibilities for 
elaborating the sidechain in the 3-position of indoline-2-ones into useful 
intermediates in the synthesis of indole alkaloids (Fig. 4.19). 
RO 
RO 
RO 
(Michael) 
0 ·------------~ 
C02Et 
R-1 
RO 
0 ·------------~ 
·------------
·------------
(Alk.) 
·------------~ 
Fig. 4.19 Hypothetical synthesis of substituted physostigmine derivatives. 
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General experimental 
Melting points were determined on a Reichert hot-stage apparatus 
and are uncorrected and microanalyses were carried out by the 
Australian National University Microanalytical Service. 
Low resolution electron impact mass spectra (EI-MS) and high 
resolution accurate mass measurements were recorded on a VG 
Micromass 7070F double-focussing mass spectrometer (low resolution EI-
MS only), or a VG ZAB-2SEQ spectrometer. The molecular ion (M+•), if 
present, significant high mass ions and the more intense low mass ions 
are reported. Chemical ionisation mass spectra (CI-MS) were obtained on 
the VG Micromass 7070F double-focussing mass spectrometer, using 
ammonia as the reagent gas. 
Infrared spectra were recorded on a Perkin-Elmer 683 or Perkin-
Elmer 1800 (FT) spectrophotometer as films (neat) or in dichloromethane 
(DCM) solution. The following abbreviations were adopted to indicate 
the intensity and shape of the band: s (strong), m (medium), w (weak) 
and b (broad). 
lH-NMR spectra were recorded on a Varian Gemini-300 (300 MHz), 
Varian VXR-300 (300 MHz) or a Varian VXR-500 (500 MHz). Unless 
otherwise stated the spectra were recorded at 300 MHz. Tetramethylsilane 
(TMS) was used as internal reference and the signals are quoted in 
8 values (ppm downfield from TMS). The following abbreviations were 
adopted to indicate the multiplicity and shape of the signal: 
s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), m (multiplet), 
b (broad) and app (apparent). Deuterated chloroform (CDCb) was used as 
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solvent unless otherwise stated. The chemical shift of diastereomers are 
. e. 
m par,4ntheses. 
13C-NMR spectra were recorded on a Varian Gemini-300 (75.5 MHz), 
the solvent signal was used as internal reference (CDCl3: 76.9 ppm, 
C0300: 49.0 ppm, Acetone-d6, 206.5 ppm). The chemical shift of 
diastereomers are in parantheses. 
All solvents and reagents were purified and dried according to the 
procedure of Perrin and Amarego.51 In addition, all organic solvents 
were distilled directly from drying agents prior to use. All reactions 
unless otherwise stated were performed under a dry argon athmosphere. 
All reaction temperatures refer to bath temperatures with -78 °C and O °C 
corresponding to dry ice/acetone and ice/water baths respectively. Unless 
otherwise stated drying of organic extracts was done by stirring with 
magnesium sulphate for ca. 15 min. 
All chromatography unless otherwise stated was carried out using 
vacuum liquid chromatography (VLC) using Merck silica gel 60 
containing gypsum according to Coll & Bowden.52,53,54 Analytical thin 
layer chromatography was done on precoated aluminium Merck silica 
gel 60 PF254 plates and visualised under ultr(yiolet light (254 nm or 350 
nm), by spraying with a 13°/o solution of vanillin in sulphuric acid or 
dipping in a 3% solution of fhosphomolybdic acid in absolute ethanol 
followed by heating at ca. 200 °C. 
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Experimental 
3-Ethylindoline-2-one (4.14). 
To a solution of oxindole (lg, 7.5 mmol) in dichloromethane (20 ml) 
was added neutral alumina (10 g) and the slurry stirred for 15 min. 
Acetaldehyde ( 400 mg, 9 mmol) was added and the mixture stirred until 
TLC showed complete conversion of starting material (4 h). The alumina 
was removed by filtration, washed thoroughly with dichloromethane 
and the filtrate concentrated in vacuo. The orange solid was redissolved 
in methanol (30 ml) and hydrogenated at room temperature and 
atmospheric pressure over palladium on carbon (150 mg). The reaction 
mixture was filtered through Celite and the solvent evaporated. 
Recrystallisation from ethanol gives 4.14 (1.04 g, 86 °/o). Mp: 103-4 °C. 
Microanalysis: Found C: 73.30, H: 6.78, N: .8.49. Calculated C: 74.51, H: 6.88, 
N: 8.69. 
lH-NMR (300 Mz, CDCl3) 8: 0.93 (t, J = 7.3 Hz, H2'), 2.03 (ddd, J = 5.5, 7.3, 
12.8 Hz, Hl'a), 2.05 (ddd, J = 5.5, 7.3, 12.8 Hz, Hl'b ), 3.47 (t, J = 5,5 Hz, H3), 
6.92 (d, J = 8.1 Hz, H4), 7.03 (t, J = 8.1 Hz, H6), 7.19 (d, J = 8.1 Hz, H7), 7.24 (t, 
J = 8.1 Hz, HS). 
13C-NMR (75.5 Mz, CDCb) 8: 10.0 (C2'), 23.6 (Cl'), 47.2 (C3), 109.8 (C7), 
122.2 (CS), 124.1 (C6), 127.8 (C4), 129.5 (C9), 141.9 (C8), 181.0 (CO). 
(Z)-3-(3' -methyl-2' -butenylidene)-indoline-2-one (4.17) and (E)-3-(3' -
methyl-2' -bu tenylidene )-indoline-2-one ( 4.18). 
To a solution of oxindole (lg, 7.5 mmol) in dichloromethane 
(20 ml) was added neutral alumina (10 g) and the slurry stirred for 15 
min. 3-Methylbutenal (750 mg, 8.9 mmol) was added and the mixture 
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stirred until TLC showed complete conversion of starting material (7 h). 
The alumina was removed by filtration, washed thoroughly with 
dichloromethane and the filtrate concentrated in vacuo. The isomers 
were separated by VLC on silica gradient eluted with hexane/ ethyl acetate 
(90:10 --t 50:50) to give 4.17 (130 mg, 8 °/o) and 4.18 (1.1 g, 76 °/o). 
4.17 mp: 212-14 °C. (Lit.41 213-14 °C). 
Microanalysis: Found C: 78.67, H: 6.94, N: 6.92, Calculated C: 78.36, H: 6.58, 
N: 7.03. 
IR (Ymax, cm-1): 2800-3100 m, 1686 s, 1604 s, 1193 ms, 745 s. 
EIMS m/z (0/o): 199 (63) [M]+, 184 (100) [M-Me]+, 170 (45), 128 (38), 86 (34). 
lH-NMR (300 Mz, CDCl3) o: 2.03 (s, E-Me), 2.04 (s, Z-Me), 6.86 (d, J = 7.7 
Hz, H7), 6.99 (t, J = 7.7 Hz, H6), 7.17 (t, J = 7.7 Hz, HS), 7.44 (d, J = 7.7 Hz, 
H4), 7.50 (d, J = 12.2 Hz, Hl'), 7.61 (dd, J = 2.2, 12.2 Hz, H2'). 
13C-NMR (75.5 Mz, CDCb) o: 18.1, 26.8, 109.4, 116.6, 121.2, 121.3, 122.2, 
124.3, 127.8, 132.4, 139.5, 150.2, 176.9. 
4.18 mp: 200-2 °C. (Lit.41 200-3 °C). 
Microanalysis: Found C: 78.52, H: 6.95, N: 6.99. Calculated C: 78.36, H: 6.58, 
N: 7.03. 
IR (Ymax, cm-1): 2800-3100 m, 1708 s, 1606 s, 1207 m, 743 m. 
EIMS m/z (0/o): 199 (60) [M]+, 184 (100) [M-Me]+, 170 (22), 130 (27), 77 (16). 
lH-NMR (300 Mz, CDCl3) o: 2.07 (s, E-Me), 2.08 (s, Z-Me), 6.81 (dd, J = 1.8, 
12.8 Hz, H2'), 6.90 (d, J = 7.7 Hz, H7), 7.03 (t, J = 7.7 Hz, H6), 7.20 (t, J = 7.7 
Hz, HS), 7.60 (d, J = 12.8 Hz, Hl'), 7.63 (d, J = 7.7 Hz, H4). 
13C-NMR (75.5 Mz, CDCl3) o: 19.0, 27.6, 110.4, 121.7, 122.2, 123.8, 128.4, 
128.6, 133.1, 141.2, 153.0, 171.7. 
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Ethyl hydroxyisatyliden~cetate. 
\,,./ 
Oxindol (2 g, 15 mmol) was dissolved in ethanolic sodium ethoxide 
made from sodium (690 mg, 30 mmol) in 100 ml abs. ethanol. Diethyl 
oxalate (2.3 g, 20 mmol) was added and the mixture stirred under reflux 
for 3 h. The reaction mixture was diluted with 200 ml 5°/o hydrochloric 
acid cooled and filtered. Recrystallisation from ethanol or ethanol/water 
afforded the enol as orange needles (3.4 g, 96°/o) m.p.: 186-88 °C (lit .24 187 
oc). 
Microanalysis: Found C: 61.82, H: 4.63, N: 5.95. Calculated C: 61.80, H: 4.75, 
N: 6.01. 
IR (Ymax, cm-1): 2800-3100 b, 1730 s, 1706 s, 1463 ms, 1296 s, 1213 s, 751 ms. 
EIMS m/z (0/o): 233 (57) [M]+, 160 (100), 132 (36), 104 (42), 77 (51). 
lff-NMR (300 Mz, CDC!J) 8: 1.45 (t, J = 7.1 Hz, CH2CH3), 4.48 (q, J = 7.1 Hz, 
CH2CH3), 7.01 (d, J = 8.1 Hz, H7)~ 7.10 (t, J = 8.1 Hz, H6), 7.22 (t, J = 8.1 Hz, 
HS), 8.17 (d, J = 8.1 Hz, H4). 
13C-NMR (75.5 Mz, CDCl3) 8: 14.1, 62.2, 107.8, 110.7, 120.1, 122.4, 124.6, 
128.0, 138.7, 155.7, 162.7, 174.4. 
Ethyl oxindolylacetate (4.20) 
V 
A suspension of ethyl hydroxyisatylidenO.cetate (3.15 g, 13.5 mmol) 
in 100 ml 1:1 ethyl acetate/ cone. acetic acid containing 70°/o perchloric acid 
(0.5 ml) was hydrogenated overnight at room temperature and 
atmospheric pressure over 10 °/o palladium on carbon (100 mg). The 
reaction mixture was filtered through celite, neutralised with an ice cold 
i"e c,tTt",cc.-r 
solution of 10°/o aqeous ammonia, extracted with ethyl acetate,;;'washed 
of t~c rei. tc:foe. 
with brine, dried and evaporated. Recrystallisation~ from ethyl 
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acetate/heptane afforded ester 4.20 (2.8 g, 86°/o) as colorless needles m.p.: 
95-97 °C (Lit.24 94-98 °C). 
Microanalysis: Found C: 65.47, H: 5.71, N: 6.14. Calculated C: 65.74, H: 5.98, 
N: 6.39. 
IR (Ymax, cm-1): 2900-3200 b, 1731 s, 1705 s, 1472 m, 1211 s, 750 ms .. 
EIMS m/z (0/o): 219 (59) [M]+, 173 (36), 145 (100), 128 (31), 117 (53), 77 (22). 
lH-NMR (300 Mz, CDCb) 8: 1.21 (t, J = 7.2 Hz, CH2CH3), 2.85 (dd, J = 7.3, 
16.5 Hz, Hl'a), 3.08 (dd, J = 5.4, 16.5 Hz, Hl'b ), 3.82 (dd, J = 5.4, 7.3 Hz, H3), 
4.14 (q, J = 7.2 Hz, CH2CH3), 4.15 (q, J = 7.2 Hz, CH2CH3), 6.91 (d, J = 7.2 Hz, 
H7), 7.02 (t, J = 7.2 Hz, H6), 7.22 (t, J = 7.2 Hz, HS), 7.26 (d, J = 7.2 Hz, H4). 
13C-NMR (75.5 Mz, CDCl3) 8: 14.4, 34.8, 42.3, 61.0, 109.8, 122.5, 124.1, 128.3, 
128.8, 141.5, 171.0, 179.2. 
Ethyl isatylideneacetate (4.21). 
0 
To a mixture of triethylphosphonoacetate (2 g, 9 mmol) and dry LiBr 
(1 g, 12 mmol) inTHF (40 ml) was added triethylamine (1.2 g, 12 mmol) 
and the mixture stirred until homogeneous. This solution is added 
slowly to a solution of isatin (1.25 g, 8.5 mmol) in THF (60 ml) at -78 °C 
and the mixture stirred at this temperature for 3 h. The reaction mixture 
was acidified with 5°/o hydrochloric acid and extracted with ethyl acetate, ar1d 1he. 
o r-3 4 "' ~, l '\:I.er of~ c $,dv~ 
_lWashed with brine dried and evaporated. Recrystallisationf from 70°/o 
ethanol afforded ester 4.21 as orange needles (1.6 g, 86°/o) m.p.: 169-70 °C. 
Microanalysis: Found C: 66.48, H: 5.23, N: 6.28. Calculated C: 66.35, H: 5.10, 
N: 6.45. 
IR (Ymax, cm-1): 2900-3200 b, 1710 s, 1613 m, 1463 m, 1322 m, 1201 s, 789 m. 
EIMS m/z (0/o): 217 (100) [M]+, 172 (83), 145 (80), 116 (72), 89 (48), 63 (23). 
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lH-NMR (300 Mz, CDCb) 8: 1.20 (t, J = 7.3 Hz, CH2CH3), 4.14 (q, J = 7.3 Hz, 
CH2CH3), 6.64 (s, Hl'), 6.72 (d, J = 7.8 Hz, H7), 6.83 (t, J = 7.8 Hz, H6), 7.12 (t, 
J = 7.8 Hz, HS), 8.34 (d, J = 7.8 Hz, H4). 
13C-NMR (75.5 Mz, CDCb) 8: 13.7, 60.7, 109.8, 119.9, 121.5, 122.0, 128.5, 
132.1, 138.1, 143.8, 165.2, 168.4. 
From an identical reaction run at room temperature was isolated, after 
VLC gradient eluted with hexane/ ethyl acetate 50:50 ~ 0:100, ester 4.21 
(1.2 g, 69°/o) and biproduct 4.22 (561 mg, 15°/o). 4.22 was recrystallised from 
ethanol to give colorless crystals. M.p.: 155-60 °C. 
Microanalysis: Found C: 54.27, H: 6.50, N: 3.06. Calculated C: 54.42, H: 6.39, 
N: 3.17. 
IR (Ymax, cm-1 ): 3364 ms, 1736 m, 1700 s, 1208 s, 747 m. 
EIMS m/z (0/o): 441 (73) [M]+, 396 (59), 321 (83), 275 (75), 247 (70), 224 (81), 
198 (92), 185 (87), 172 (100), 152 (78), 132 (72), 123 (54). 
lH-NMR (300 Mz, CDCb) 8: 0.76 (t, J = 7.2 Hz), 1.30 (t, J = 7.3 Hz), 1.39 (t, 
J = 7.4 Hz), 1.41 (t, J = 7.4 Hz), 3.78 (4H, m), 4.26 (7H, m), 6.89 (d, J = 7.7 Hz, 
H7), 6.96 (t, J = 7.7 Hz, H6), 7.18 (t, J = 7.7 Hz, HS), 7.26 (d, J = 7.7 Hz, H4). 
Ethyl oxindolyl acetate (4.20). V 
The ester x (1.5 g, 6.9 mmol) was hydrogenated in methanol (100 ml) 
containing 10°/o palladium on carbon (100 mg) at atmospheric pressure 
and room temperature. The reaction mixture was filtered through celite 
and the filtrate concentrated in vacuo leaving practically pure ester 4.20 
(1.45 g, 98°/o) as colorless needles. Recrystallisation from ethyl 
acetate/heptane. Physical data: see above. 
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Oxindolylacetaldehyde (4.23) 
To a solution of ethyl oxindolyQcetate 4.20 (2 g, 9.1 mmol) in 
dichloromethane (80 ml) was added dropwise DIBAL-H (19 ml, lM 
solution in hexane, 19 mmol) at -78 °C. with stirring. Stirring was 
continued until TLC showed complete conversion of the starting 
material. Excess methanol was added and stirring continued for 10 min. 
The mixture was diluted with 5 °/o hydrochloric acid and the two phases 
separated. The aqueous layer was extracted twice with ethyl acetate, the 
0 combined organic phases dried (MgS04) and evaifrated. Recrystallisation 
from ethanol gave aldehyde 4.23 (1.3 g, 81 °/o). Mp: 112-14 °C. 
Microanalysis: Found C: 62.38, H: 5.92, N: 7.05. Calculated C: 62.17, H: 5.74, 
N: 7.25. 
EIMS m/z (0/o): 175 (54) [M]+, 146 (100), 128 (46), 118 (24), 104 (17), 91 (23), 
77 (29). 
lH-NMR (300 Mz, CDCb) o: 2.98 (dd, J = 8.4, 19.3 Hz, Hl'a), 3.29 (dd, J = 
4.6, 19.3 Hz, Hl'b), 3.95 (dd, J = 4.6, 8.4 Hz, H3), 6.92 (d, J = 8.0 Hz, H7), 7.02 
(t, J = 8.0 Hz, H6), 7.20 (t, J = 8.0 Hz, HS), 7.23 (d, J = 8.0 Hz, H4), 9.91 (s, 
CHO). 
13C-NMR (75.5 Mz, CDCl3) o: 14.2, 36.6, 42.4, 62.3, 121.6, 123.7, 127.4, 128.9, 
141.5, 180.7, 208.3. 
3-Hydroxyethylindolin-2-one (4.24). 
To a solution of ester 4.20 (300 mg, 1.4 mmol) in of THF (20 ml) was 
added LiBH4 (92 mg, 4.2 mmol) and the mixture stirred at 45 °C until TLC 
showed complete conversion of starting material (1 h.). Water (20 ml) 
was added and the reaction mixture made acidic by addition of 5°/o 
hydrochloric acid. The two phase system was thoroughly extracted with 
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ethyl acetate, washed with brine, dried an evaporated. Purification by 
VLC, gradient eluted with hexane/ ethyl acetate 40:60 ~ 0:100 afforded 
tryptophol 4.25 (7 mg, 3°/o) and the alcohol 4.24 (250 mg, 83°/o) mp:: 
112-14 °C. 
Microanalysis: Found C: 67.31, H: 6.21, N: 7.74. Calculated C: 67.78, H: 6.26, 
N: 7.90. 
IR (Yrnax, cm-1): 2900 - 3400 b, 1692 s, 1472 ms, 1213 m, 1038 ms, 760 m. 
EIMS m/z (0/o): 177 (79) [M]+, 159 (46), 146 (100), 133 (45), 117 (23), 104 (21), 
91 (17), 77 (28), 65 (9). 
lH-NMR (300 Mz, CDCb) o: 2.11 (ddt, J = 3.1, 5.7, 14.5 Hz, Hl'a), 2.27 (ddt, 
J = 5.7, 8.4 14.5 Hz, Hl'b), 3.63 (dd, J = 3.1, 8.4 Hz, H3), 3.88 (2H, t, J = 5.4 Hz, 
H2'), 6.92 (d, J = 7.6 Hz, H7), 7.04 (t, J = 7.6 Hz, H6), 7.22 (t, J = 7.6 Hz, HS), 
7.25 (d, J = 7.6 Hz, H4). 
13C-NMR (75.5 Mz, CDCl3) o: 32.9, 44.1, 59.7, 109.8, 122.3, 123.8, 127.8, 
129.3, 141.4, 181.6. 
3-Acetoxyethylindolin-2-one ( 4.28). 
To the alcohol 4.24 (277 mg, 1.6 mmol) and vinyl acetate (1.3 g, 16 
mmol) in dichloromethane (20 ml) was added immobilised lipase (30 
mg) and the mixture shaken slowly (60 rpm) until TLC showed complete 
conversion of starting material (12 h.). The reaction mixture was filtered 
and the volatiles evaporated leaving practically pure acetate 4.28 (343 mg, 
98°/o) mp: 85-7 °C. 
Microanalysis: Found C: 65.38, H: 5.72, N: 6.08. Calculated C: 65.74, H: 5.98, 
N: 6.39. 
IR (Ymax, cm-1): 2800-3200 b, 1742 ms, 1730 ms, 1696 s, 1473 ms, 752 m. 
EIMS m/z (0/o): 219 (65) [M]+, 177 (73), 159 (100), 146 (85), 130 (64), 117 (24), 
104 (17), 90 (11), 77 926). 
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lH-NMR (300 Mz, CDCl3) 8: 1.95 (s, COMe), 2.32 (2H, m, Hl '), 3.59 (t, J = 
6.3 Hz, H3), 4.24 (2H, m, H2'), 6.93 (d, J = 8.1 Hz, H7), 7.02 (t, J = 8.1 Hz, 
H6), 7.21 (t, J = 8.1 Hz, HS), 7.24 (d, J = 8.1 Hz, H4) .. 
13C-NMR (75.5 Mz, CDCb) 8: 32.9, 44.1, 59.7, 109.8, 122.3, 123.8, 127.8, 
129.3, 141.4, 181.6. 
3-Acetoxyethyl-3-hydroxyindolin-2-one (4.29). 
To the acetate 4.28 (395 mg, 1.8 mmol) in dichloromethane (10 ml) 
was added dropwise a solution of bromine (304 mg, 1.9 mmol) in 
dichloromethane (10 ml) with stirring. When TLC showed complete 
consumption of starting material the solvent was evaporated and the 
mixture redissolved in 20 ml 50°/o aqueous t-butanol containing sodium 
bicarbonate (252 mg, 3 mmol). The mixture was stirred at room 
temperature until complete conversion of starting material. (8 h), diluted 
with water (50 ml) and extracted thoroughly with ethyl acetate, washed 
with brine, dried and evaporated. Purification by VLC gradient eluted 
with hexane/ethyl acetate 60:40 ~ 0:100 afforded 4.29 (367 mg, 93°/o) 
mp: 127-9 °C. 
Microanalysis: Found C: 60.98, H: 5.32, N: 5.35. Calculated C: 61.27, H: 5.57, 
N: 5.95. 
IR (Vmax, cm-1): 2900-3400 b, 1744 ms, 1709 s, 1248 ms, 1231 ms, 751 m. 
EIMS m/z (0/o): 235 (79) [M]+, 207 (11), 175 (62), 148 (100), 132 (25), 120 (83), 
104 (13), 92 (47), 77 (24), 65 (40). 
1H-NMR (300 Mz, CDCl3) 8: 1.89 (s, COMe), 2.33 (dt, J = 6.3, 6.3, 12.4 Hz, 
Hl'a), 2.35 (dt, J = 6.3, 6.3, 12.4 Hz, Hl'b), 4.01 (ddd, J = 6.8, 6.8, 11.3 Hz, 
H2'a), 4.17 (ddd, J = 6.3, 6.3, 11.3 Hz, H2'b) 6.87 (d, J = 7.9 Hz, H7), 7.00 (t, J = 
7.9 Hz, H6), 7.20 (t, J = 7.9 Hz, HS), 7.32 (d, J = 7.9 Hz, H4). 
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13C-NMR (75.5 Mz, CDCb) 8: 20.0, 35.9, 59.3, 74.1, 109.6, 121.5, 123.5, 128.6, 
130.4, 140.8, 170.0, 179.1. 
3-Hydroxyethyl-3-hydroxyindolin-2-one (4.30). 
The hydroxy acetate 4.29 ( 420 mg, 1.8 mmol) was dissolved in 20 ml 
methanol containing 0.5 °/o sodium methoxide and the mixture stirred at 
room temperature until complete consumption of starting material ( 4 
h.). The solvent was evaporated leaving practically pure diol 4.30 (331 
mg, 96°/o). An analytically pure sample was recrystallised from ethyl 
acetate/hexane. Mp: 139-41 °C. 
Microanalysis: Found C: 61.51, H: 5.38, N: 6.94. Calculated C: 62.17, H: 5.74, 
N: 7.25. 
IR (Ymax, cm-1): 2900-3400 b, 1706 s, 1626 ms, 1475 m, 1079 ms, 751 m. 
EIMS m/z (0/o): 193 (77) [M]+, 175 (17), 165 (24), 148 (100), 130 (20), 120 (86), 
102 (14), 92 (56), 77 (33), 65 (48). 
lH-NMR (300 Mz, CDCb) 8: 2.04 (2H, m, Hl'), 3.71 (2H, m, H2'), 6.90 (d, 
J = 8.0 Hz, H7), 7.02 (t, J = 8.0 Hz, H6), 7.21 (t, J = 8.0 Hz, HS), 7.37 (d, J = 8.0 
Hz, H4). 
13C-NMR (75.5 Mz, CDCb) 8: 20.0, 35.9, 59.3, 74.1, 109.6, 121.5, 123.5, 128.6, 
130.4, 140.8, 170.0, 179.1. 
3-Hydroxy-3-tosyloxyethylindolin-2-one (4.31). 
To the diol 4.30 (400 mg, 2.1 mmol) in neat pyridine (10 ml) was 
added p-toluenesulphonyl chloride (395 mg, 2.1 mmol) and the mixture 
stirred for 3 h. The reaction mixture was poured onto a mixture of ice 
and 5°/o hydrochloric acid and extracted with ethyl acetate, washed with 
of the r'GS idve 
brine, dried and evaporated. Purificationj by VLC gradient eluted with 
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hexane/ethyl acetate 50:50 ~ 0:100 afforded the tosylate 4.31 (678 mg, 
93°/o). Mp: 144-5 °C. 
Microanalysis: Found C: 59.00, H: 5.19, N: 4.02. Calculated C: 58.78, H: 4,93, 
N: 4.03. 
EIMS m/z (0/o): 347 (56) [M]+, 319 (11), 172 (83), 159 (35), 147 (71), 119 (50), 
107 (58), 91 (100), 77 (40), 65 (59). 
lH-NMR (300 Mz, acetone-d6) 8: 2.32 (ddd, J = 5.5, 8.3, 13.8 Hz, Hl'a), 2.44 
(ddd, J = 6.8, 8.5, 13.8 Hz, Hl'b), 2.58 (s, Me), 4.26 (ddd, J = 6.8, 8.5, 10.1 Hz, 
H2'a), 4.37 (ddd, J = 5.5, 8.3, 10.1 Hz, H2'b), 6.99 (d, J = 7.7 Hz, H7), 7.11 (t, J = 
7.7 Hz, H6), 7.35 (t, J = 7.7 Hz, HS), 7.41 (d, J = 7.7 Hz, H4), 7.56 (d, J = 8.1 Hz, 
H3", HS"), 7.84 (d, J = 8.1 Hz, H2", H6") 
13C-NMR (75.5 Mz, acetone-d6) 8: 20.9, 36.8, 66.4, 74.2, 110.2, 122.3, 124.4, 
128.0, 129.7, 130.2, 131.2, 133.4, 141.8, 145.2, 178.2. 
3-Methylaminoethyl-3-hydroxyindolin-2-one (4.5). 
The tosylate 4.31 (360 mg, 1.1 mmol) was added to a 30 °/o solution of 
methylamine in ethanol (20 ml) and the mixture stirred under reflux for 
5 h. The volatiles were evaporated, water was added and the mixture 
extracted with ethyl acetate (Sx). The ethy~cetate extract was washed with 
saturated aqueous sodium bicarbonate, dried and evaporated . 
of -t" ,.c:, 1d11e 
Purificatiorxby VLC gradient eluted with hexane/ ethyl acetate 50:50 ~ 
0:100 afforded donaxaridine 4.5 (190 mg, 89°/o). Mp: 179-80 °C. (Lit.5 175-
76 °C) 
Microanalysis: Found C: 64.04, H: 7.14, N: 13.43. Calculated C: 64.06, H: 
6.84, N: 13.58. 
IR (Ymax, cm-1 ): 3452 m, 2900-3300 ms, 1674 s, 1496 m, 1307 m, 751 m. 
EIMS m/z (0/o): 206 (97) [M]+, 188 (23), 173 (16), 159 (11), 146 (64), 135 (59), 
120 (100), 92 (57), 77 (18), 65 (55), 58 (82). 
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lH-NMR (300 Mz, CDCl3) 8: 2.42 (ddd, J = 9.0, 9.0, 12.7 Hz, Hl'a), 2.75 (ddd, 
J = 1.5, 6.2, 12.7 Hz, Hl'b), 2.96 (s, NHMe), 3.24 (ddd, J = 6.2, 9.0, 9.0 Hz, 
H2'a), 3.33 (ddd, J = l.5, 9.0, 9.0 Hz, H2'b), 6.69 (t, / = 8.7 Hz, H6), 6,71 (d, J = 
8.7 Hz, H7), 6.86 (d, J = 8.7 Hz, H4), 7.11 (t, / = 8.7 Hz, HS). 
13C-NMR (75.5 Mz, CDCb) 8: 30.1 (NHMe), 32.9 (Cl'), 45.6 (C2'), 79.3 (C3), 
118.0 (C7), 118.3 (CS), 125.2 (C9), 125.6 (C6), 129.1 (C4), 145.8 (C8), 175.1 (CO). 
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Crystallography of 3.2 
A colourless rod-shaped crystal of C17H22010 having approximate 
dimensions of 0.25 x 0.20 x 0.15 mm was mounted on a glass fiber . All 
measurements were made on a Rigaku AFC6R diffractometer with 
graphite monochromated Cu-Ka radiation and a 12kW rotating anode 
generator. 
The spacegroup contain two independent molecules which are very 
close to being related by a two-fold screw axis through (0.000 0.274 0.750) 
and (0.255 0.524 0.000). 
A. Crystal Data 
Empirical Formula 
Formula Weight 
Crystal Colour, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type 
No. of Reflections Used for Unit 
Cell Determination (28 range) 
Omega Scan Peak Width 
at Half-height 
Lattice Parameters 
Space Group 
Z value 
Deale 
Fooo 
µ(CuKa) 
C17H22010 
386.35 
colourless, rod 
0.25 x 0.20 x 0.15 mm 
monoclinic 
Primitive · 
16 ( 64.0- 79.1°) 
0.42° 
a= 12.121(2)A 
b = 5.090(1) A 
c = 31.316(4) A 
b = 90.61(1) 0 
V = 1932.1(5) A3 
P21 (#4) 
4 
1.328 g/cm3 
816.00 
9.52 cm-1 
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B. Intensity Measurements 
Diffractometer 
Radiation 
Take-off Angle 
Detector Aperture 
Crystal to Detector Distance 
Temperature 
Scan Type 
Scan Rate 
Scan Width 
20max 
No. of Reflections Measured 
Corrections 
Rigaku AFC6R 
CuKa (A = 1.54178 A) 
graphite monochromated 
6.0° 
9.0 mm horizontal 
9.0 mm vertical 
400 mm 
-60.0°C 
(t}-2q 
16.0° /min (in ro) (up to 4 scans) 
(1.50 + 0.30 tan 0) 0 
120.3° 
Total: 3438 
Unique: 3267 (Rint = 0.027) 
Lorentz-polarization 
Absorption ( trans. factors: 
0.9052 - 0.9490) 
Decay (1.12°/o decline) 
Secondary Extinction 
(coeff: 4.41 x 10-7) 
C. Structure Solution and Refinement 
Structure Solution 
Refinement 
Function Minimized 
Least Squares Weights 
p-factor 
Anomalous Dispersion 
No. Observations (I>3cr(I)) 
No. Variables 
Reflection/ Parameter Ratio 
Residuals: R; Rw 
Goodness of Fit Indicator 
Max Shift/Error in Final Cycle 
Maximum peak in Final Diff. Map 
Minimum peak in Final Diff. Map 
Direct Methods (SIR92)55,56 
Full-matrix least-squares 
L m( I F0 I - I Fe I )2 
l/cr2(F0 ) = 4F0 2/cr2(F0 2) 
0.0050 
All non-hydrogen atoms57,58 
2401 
511 
4.70 
0.061 ; 0.052 
3.29 
0.06 
0.24 e-1 A3 
-0.25 e-1 A3 
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0110 
0109 
0108 Cl 15 
0107 Cl07 
0103 
0104 
- - -- --·~- - -- - --
Fig. 1 ORTEP diagram of the first C17H22010 molecule with labeling of 
non-hydrogen atoms 
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0210 
0208 C215 
C2IO 
0202 
0203 
Fig. 2 ORTEP d_iagram of the second C17H22Dm molecule with labeling of 
non-hydrogen atoms 
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Coordinates and Isotropic Displacement Parameters for C17H22010 
atom X y z Beq 
0(101) 0.3856(4) 0.5000 0.6423(2) 3.9(2) 
0(102) 0.4609(5) 0.769(2) 0.5932(2) 4.6(2) 
0(103) 0.6711(4) 0.589(2) 0.6156(2) 5.0(2) 
0(104) 0.6878(5) 0.392(2) 0.7005(2) 4.0(2) 
0(105) 0.5032(5) 0.053(2) 0.7216(2) 4.9(2) 
0(106) 0.2207(4) 0.789(2) 0.4425(2) 5.9(2) 
0(107) 0.2068(4) 0.131(2) 0.6606(2) 5.6(2) 
0(108) 0.0690(4) 0.302(2) 0.6981(2) 4.7(2) 
0(109) -0.1597(5) -0.082(2) 0.6179(2) 5.6(2) 
0(110) -0.2181(4) -0.103(2) 0.7069(2) 4.7(2) 
0(201) 0.8751(4) 0.047(2) 0.8577(2) 4.5(2) 
0(202) 0.9535(5) -0.221(2) 0.9067(2) 5.0(2) 
0(203) 1.1635(6) -0.039(2) 0.8845(2) 5.3(2) 
0(204) 1.1739(5) 0.150(2) 0.7987(2) 4.4(2) 
0(205) 0.9854(5) 0.480(2) 0.7762(2) 5.9(2) 
0(206) 0.7241(5) -0.237(2) 1.0581(2) 6.4(2) 
0(207) 0.6982(4) 0.419(2) 0.8393(2) 5.9(2) 
0(208) 0.5551(4) 0.247(2) 0.8029(2) 5.2(2) 
0(209) 0.3313(5) 0.636(2) 0.8813(2) 5.8(2) 
0(210) 0.2652(6) 0.646(2) 0.7928(3) 5.2(2) 
C(lOl) 0.4766(7) 0.536(3) 0.6158(2) 3.5(2) 
C(102) 0.5808(7) 0.574(2) 0.6430(2) 3.8(2) 
C(l03) 0.5967(6) 0.343(2) 0.6726(2) 3.1(2) 
C(l04) 0.4934(6) 0.292(2) 0.6982(2) 3.4(2) 
C(105) 0.3940(6) 0.266(2) 0.6679(2) 3.3(2) 
C(106) 0.3928(7) 0.765(3) 0.5560(2) 3.8(2) 
C(107) 0.3128(7) 0.585(3) 0.5488(3) 4.6(3) 
C(108) 0.2520(7) 0.595(3) 0.5101(3) 4.6(3) 
C(l09) 0.2778(7) 0.782(3) 0.4809(3) 4.8(3) 
C(llO) 0.3615(7) 0.963(3) 0.4884(3) 4.4(2) 
C(lll) 0.4177(7) 0.952(3) 0.5268(3) 4.3(2) 
C(112) 0.2878(6) 0.236(3) 0.6915(3) 4.8(3) 
C(113) 0.1029(6) 0.168(3) 0.6702(3) 3.8(2) 
C(114) 0.0272(6) 0.017(3) 0.6395(3) 4.1(2) 
C(ll5) 0.0657(7) -0.108(4) 0.6064(3) 9.9(5) 
C(116) -0.0924(6) 0.020(2) 0.6515(3) 3.8(2) 
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atom X y z Beq 
C(117) -0.0924(6) 
-0.148(2) 0.6906(3) 3.7(2) 
C(201) 0.9683(7) 0.011(3) 0.8840(2) 3.8(2) 
C(202) 1.0701(7) -0.026(2) 0.8561(2) 3.8(2) 
C(203) 1.0824(6) 0.199(2) 0.8263(2) 3.2(2) 
C(204) 0.9780(6) 0.244(3) 0.8012(2) 3.7(2) 
C(205) 0.8812(7) 0.279(3) 0.8315(2) 4.1(2) 
C(206) 0.8905(8) -0.212(3) 0.9438(3) 4.6(3) 
C(207) 0.8110(8) -0.035(3) 0.9523(3) 5.1(3) 
C(208) 0.7534(6) -0.044(3) 0.9906(3) 4.9(3) 
C(209) 0.7792(7) -0.235(3) 1.0201(3) 4.7(3) 
C(210) 0.8625(7) -0.412(3) 1.0120(3) 4.8(3) 
C(211) 0.9169(7) -0.401(3) 0.9738(3) 4.5(3) 
C(212) 0.7735(6) 0.298(3) 0.8083(3) 5.8(3) 
C(213) 0.5916(7) 0.386(3) 0.8309(3) 4.2(2) 
C(214) 0.5187(6) 0.539(3) 0.8599(3) 4.6(3) 
C(215) 0.5597(9) 0.665(4) 0.8925(4) 10.0(5) 
C(216) 0.3973(7) 0.530(3) 0.8487(3) 4.3(2) 
C(217) · 0.3744(7) 0.692(3) 0.8095(3) 4.7(3) 
H(lOl) 0.4846 0.3912 0.5969 4.0966 
H(102) 0.5756 0.7313 0.6591 4.6585 
H(103) 0.6130 0.1912 0.6560 3.7122 
H(104) 0.4823 0.4330 0.7173 4.0331 
H(105) 0.4038 0.1191 0.6495 4.0213 
H(107) 0.2957 0.4563 0.5697 5.4511 
H(108) 0.1955 0.4713 0.5044 5.4928 
H(llO) 0.3817 1.0889 0.4672 5.2744 
H(lll) 0.4734 1.0790 0.5331 5.0557 
H(112a) 0.2981 0.1170 0.7146 5.8181 
H(112b) 0.2646 0.4011 0.7020 5.8181 
H(115a) 0.0174 
-0.2082 0.5884 12.2504 
H(115b) 0.1425 
-0.1049 0.6006 12.2504 
H(116) 
-0.1142 0.1957 0.6574 4.7374 
H(117a) 
-0.1064 
-0.3267 0.6833 4.6321 
H(117b) 
-0.0612 
-0.1029 0.7122 4.6321 
H(l90) 
-0.2489 
-0.2686 0.7049 6.8193 
H(193) 0.7284 0.7012 0.6163 6.8193 
H(194) 0.696(7) 0.26(2) 0.715(3) 6.8193 
H(195) 0.512(6) 0.06(2) 0.750(2) 6.8193 
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atom X y z Beq 
H(196) 0.2595 0.8913 0.4224 6.8193 
H(199) -0.178(6) 0.05(2) 0.593(3) 6.8193 
H(201) 0.9777 0.1557 0.9029 4.4984 
H(202) 1.0651 -0.1839 0.8403 4.4898 
H(203) 1.0976 0.3524 0.8424 3.7675 
H(204) 0.9639 0.0979 0.7828 4.5958 
H(205) 0.8932 0.4306 0.8488 4.8438 
H(207) 0.7934 0.0972 0.9320 5.8811 
H(208) 0.6970 0.0782 0.9964 5.9611 
H(210) 0.8814 -0.5402 1.0326 5.6641 
H(211) 0.9749 
-0.5224 0.9681 5.4949 
H(212a) 0.7793 0.4057 0.7836 6.9524 
H(212b) 0.7472 0.1295 0.8003 6.9524 
H(215a) 0.5121 0.7625 0.9107 12.1986 
H(215b) 0.6369 0.6662 0.8976 12.1986 
H(216) 0.3765 0.3535 0.8436 4.9648 
H(217a) 0.3833 0.8725 0.8164 5.5280 
H(217b) 0.4273 0.6458 0.7883 5.5280 
H(290) 0.249(9) 0.80(2) 0.792(4) 6.8193 
H(293) 1.191(8) 
-0.14(2) 0.872(3) 6.8193 
H(294) 1.175(8) 0.25(2) 0.781(3) 6.8193 
H(295) 1.022(6) 0.45(2) 0.752(2) 6.8193 
H(296) 0.7647 
-0.3379 1.0782 6.8193 
H(299) 0.325(7) 0.54(2) 0.904(3) 6.8193 
Beq = 8/3 p2(U11(aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U12(aa*bb*)cos g + 
2U13(aa*cc*)cos b + 2U23(bb*cc*)cos a) 
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Errata 
Change 'no' to 'any'. 
Change 'occurring' to 'occurs'. 
'Gram positives;' should read 'Gram positive bacteria;' 
'Gram negatives;' should read 'Gram negative bacteria;' 
'which makes it simpler to' should read 'which makes it simpler to 
decide which method to choose to solve a given problem.' 
After ' ( + )-(R)-3-Hydroxy-2-methylene-y-butyrolactone.' 
add: '3.2 (340 mg, 0.9 mmol) in 0.1 M hydrochloric acid (10 ml) was 
stirred, at 80 °C, until TLC showed complete disappearance of the 
starting material. The mixture was cooled and extracted with ethyl 
acetate (5 x 5 ml). The organic extract was dried and the solvent 
evaporated. The remaining oil was purified by VLC on silica and eluted 
with hexane/ethylacetate (85: 15) to give 3.3, 91 mg, 90%.' 
'3.12' should read '3.13'. 
Change internal double bond in structure to an epoxide. 
Legend should read '1 H NMR comparison of P-caryophyllene 
derivatives.' 
'Manilla' should read 'Manila'. 
'Phillippines' should read 'Philippines'. 
should be 'Planta Med., 60, 516 (1994).' 
should read 'J. Mann, R. S. Davidson, J. B. Hobbs, D. V. Banthorpe, 
J. B. Harbome.' 
should read 'E. N. Frankel, A. L. Waterhouse, J. E. Kinsella'. 
should read T. Ziegler, H. Mohler, F. Effenberger.' 
should read 'T. Jaipetch, S. Kanghae, V. Patrick, A. H. White'. 
should read 'S. Backens, W. Steglich, B. Steffan, L. Zechlin, T. Anke'. 
'increasing with the temperature' should read 'the proportion of which 
increased with temperature' 
should read 'Calculated for C10H11NO'. 
should read 'Calculated for C 13H 13N O '. 
should read 'Calculated for C13H13NO'. 
should read 'Calculated for C12H11N04'. 
should read 'Calculated for C12H13N03'. 
should read 'the extract was washed with brine ... ' 
should read 'Calculated for C12H11N03'. 
should read 'Calculated for C12H11N03'. 
'x' should read '4.21'. 
should read 'Calculated for C10H9N02'. 
should read 'Calculated for C10H11N02'. 
should read 'Calculated for C12H13N03 '. 
should read 'Calculated for C12H13N04'. 
should read 'Calculated for C10H11N03'. 
should read 'Calculated for C17H17N05S'. 
should read 'Purification of the residue by VLC ... ' 
should read 'Calculated for C11H14N202'. 
should read 'R. Stolle,' 
should read 'K. Brunner, H. Moser, Monatsch.,' 
should read 'G. Wahl,' 
